<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>EMFSA</title>
	<atom:link href="https://www.emfsa.co.za/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.emfsa.co.za/</link>
	<description>Electromagnetic fields South Africa</description>
	<lastBuildDate>Mon, 09 Nov 2026 15:25:33 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.4</generator>

<image>
	<url>https://www.emfsa.co.za/wp-content/uploads/2021/02/cropped-EMFSA_logo-fv-32x32.png</url>
	<title>EMFSA</title>
	<link>https://www.emfsa.co.za/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>5G Scientific Evidence: Research Gaps in 2026</title>
		<link>https://www.emfsa.co.za/news/5g-and-health/</link>
		
		<dc:creator><![CDATA[Editor]]></dc:creator>
		<pubDate>Mon, 09 Nov 2026 15:23:05 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Research and Studies]]></category>
		<category><![CDATA[5G]]></category>
		<category><![CDATA[5G Research]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Research Gaps]]></category>
		<guid isPermaLink="false">https://www.emfsa.co.za/?p=33319</guid>

					<description><![CDATA[<p>5G Scientific Evidence: Research Gaps in 2026 5G Scientific Evidence: Bodewein and colleagues examine the physiological and health-related effects of 5G-relevant radiofrequency fields in humans and mammals in a systematic review published in PLOS ONE on 4 November 2026. The review is titled Physiological and health-related effects of 5G-relevant radiofrequency fields: A systematic review of [&#8230;]</p>
<p>The post <a href="https://www.emfsa.co.za/news/5g-and-health/">5G Scientific Evidence: Research Gaps in 2026</a> appeared first on <a href="https://www.emfsa.co.za">EMFSA</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<h1 class="wp-block-heading"><strong>5G Scientific Evidence: Research Gaps in 2026</strong></h1>



<p class="wp-block-paragraph">5G Scientific Evidence: Bodewein and colleagues examine the physiological and health-related effects of 5G-relevant radiofrequency fields in humans and mammals in a systematic review published in <em>PLOS ONE</em> on 4 November 2026. The review is titled <em>Physiological and health-related effects of 5G-relevant radiofrequency fields: A systematic review of experimental studies in humans and mammals</em>.[1]</p>



<p class="wp-block-paragraph">The review provides a useful overview of the available experimental research, while highlighting important gaps concerning study quality, realistic exposure conditions and the absence of qualifying epidemiological studies.</p>



<p class="wp-block-paragraph">An important distinction: The review identified 107 studies that met its original eligibility criteria. The researchers later identified 28 additional articles in a supplementary search conducted in March 2026. They did not assess these additional articles in the same detail or include them in the main evidence synthesis.</p>



<figure class="wp-block-image size-full"><img fetchpriority="high" decoding="async" width="437" height="145" src="https://www.emfsa.co.za/wp-content/uploads/2026/11/5G-and-Health.jpg" alt="5G and Health: The Research Gaps" class="wp-image-33318" srcset="https://www.emfsa.co.za/wp-content/uploads/2026/11/5G-and-Health.jpg 437w, https://www.emfsa.co.za/wp-content/uploads/2026/11/5G-and-Health-300x100.jpg 300w" sizes="(max-width: 437px) 100vw, 437px" /></figure>



<p class="wp-block-paragraph"></p>



<h2 class="wp-block-heading">Where does the evidence stand?</h2>



<p class="wp-block-paragraph">The main findings are:</p>



<ul class="wp-block-list">
<li><strong>Study quality remains a concern</strong>. The researchers assigned 57 of the 107 studies to the lowest-quality category and included the remaining 50 in their main evidence assessment.</li>



<li><strong>Research specifically investigating 5G remains limited</strong>. Only five of the 50 studies included in the main evidence synthesis explicitly stated that they were investigating 5G exposure.</li>



<li><strong>There is a lack of epidemiological evidence.</strong> No epidemiological studies met the review&#8217;s eligibility criteria. This means the review could not assess possible health effects in human populations over time.</li>



<li><strong>The researchers have not fully assessed the additional studies</strong>. The 28 articles identified in the March 2026 supplementary search were not included in the main evidence synthesis.[1] </li>



<li><strong>The newer human studies provide additional observations</strong>. The five studies identified in the March search and the four papers published afterwards add to the experimental evidence, but do not resolve questions about long-term health effects.</li>



<li><strong>The newer findings do not represent four independent replications</strong>. Several of the four later papers arose from the same GOLIAT research programme, a relationship discussed in more detail below.</li>
</ul>



<p class="wp-block-paragraph">The important question is not simply whether individual studies report biological effects. It is whether the research as a whole is sufficiently reliable, independent and representative of real-world exposure to help assess possible health effects.</p>



<p class="wp-block-paragraph">The evidence remains incomplete. Researchers need to conduct more rigorous studies of longer-term exposure and real-world 5G signals.</p>



<h3 class="wp-block-heading">What did the researchers actually find?</h3>



<p class="wp-block-paragraph">The review focused on radiofrequency exposures in the 3–30 GHz range, rather than the full range of frequencies used by 5G networks.</p>



<p class="wp-block-paragraph">The researchers considered 107 experimental studies involving humans and mammals:</p>



<ul class="wp-block-list">
<li>100 animal studies;</li>



<li>Seven controlled human studies.</li>
</ul>



<p class="wp-block-paragraph">The studies investigated 23 different topics, including cognition, behaviour, male fertility, immune responses, thermoregulation, skin and eye effects.</p>



<p class="wp-block-paragraph">However, only 50 of the 107 studies were included in the main evidence synthesis. The remaining 57 were assigned to the lowest-quality tier because of their risk-of-bias assessments.</p>



<p class="wp-block-paragraph">The review found that the available evidence was limited by methodological weaknesses, inconsistent findings and a shortage of experiments using exposure conditions representative of actual 5G technology.</p>



<p class="wp-block-paragraph">The findings provide a useful assessment of the experimental evidence, but do not establish whether long-term exposure to 5G signals is safe or harmful to human health.[1]</p>



<h2 class="wp-block-heading">Why is this a concern?</h2>



<h3 class="wp-block-heading">The gap in epidemiological research</h3>



<p class="wp-block-paragraph">One of the most important findings is the absence of epidemiological studies that met the review&#8217;s inclusion criteria.</p>



<p class="wp-block-paragraph">Epidemiological research examines health outcomes in human populations. It can help investigate whether patterns of exposure are associated with particular health outcomes over time.</p>



<p class="wp-block-paragraph">The absence of qualifying epidemiological studies does not mean that no epidemiological research on radiofrequency exposure exists. It means that the reviewers did not identify studies that met their specific criteria for this assessment.</p>



<p class="wp-block-paragraph">Some studies were excluded because they examined mobile communications generally without separately assessing 5G exposure. Cross-sectional studies were also excluded because they cannot establish the temporal relationship between exposure and an outcome. Ecological studies without individual exposure assessments were not eligible either.[1]</p>



<p class="wp-block-paragraph">The authors further note that there are almost no new or ongoing epidemiological projects specifically investigating the health effects of mobile-phone exposure.[1]</p>



<h3 class="wp-block-heading">Why this gap matters</h3>



<p class="wp-block-paragraph">This leaves an important gap in the evidence. Experimental studies can investigate biological responses under controlled conditions, but they cannot replace long-term research in human populations.</p>



<p class="wp-block-paragraph">Such research is important for examining possible health outcomes associated with repeated or prolonged exposure under real-world conditions.</p>



<h2 class="wp-block-heading">How did the researchers assess the studies?</h2>



<p class="wp-block-paragraph">The review used the Office of Health Assessment and Translation (OHAT) risk-of-bias rating tool to assess the methodological quality of the studies.[1]</p>



<p class="wp-block-paragraph">The researchers divided the 107 studies into three tiers:</p>



<ul class="wp-block-list">
<li>First tier – 11 studies (10%): Low risk of bias.</li>



<li>Second tier – 39 studies (37%): Moderate risk of bias.</li>



<li>Third tier – 57 studies (53%): High risk of bias.[1]</li>
</ul>



<p class="wp-block-paragraph">Only the first- and second-tier studies were included in the main narrative evidence synthesis. The third-tier studies were not simply ignored: their information is available in the supplementary material, but the authors did not consider them sufficiently reliable for the main assessment.</p>



<p class="wp-block-paragraph">The risk-of-bias assessment identified several recurring weaknesses. These included inadequate reporting of allocation concealment and blinding, as well as insufficient descriptions of sham exposure conditions.</p>



<p class="wp-block-paragraph">Blinding is important because researchers and participants should not know whether a real or sham exposure is being administered when that knowledge could influence the conduct or assessment of an experiment.</p>



<p class="wp-block-paragraph">The authors found that many studies did not adequately describe the measures used to prevent such bias. This does not automatically mean that the results are incorrect, but it reduces confidence in the findings.</p>



<p class="wp-block-paragraph">An interesting observation was that the proportion of studies reporting biological effects increased as methodological quality decreased:</p>



<ul class="wp-block-list">
<li>59% of first-tier studies reported biological effects.</li>



<li>76% of second-tier studies reported biological effects.</li>



<li>90% of third-tier studies reported biological effects.[1]</li>
</ul>



<p class="wp-block-paragraph">The authors suggest that some findings in lower-quality studies may have resulted from factors that were not adequately controlled. This is an important possibility, but it does not demonstrate that all reported effects in those studies were false.</p>



<p class="wp-block-paragraph">The distinction between a biological effect and an adverse health effect is also important. A measurable biological response does not necessarily mean that harm has occurred.</p>



<h2 class="wp-block-heading">What did the higher-quality studies find?</h2>



<p class="wp-block-paragraph">The review identified only a small number of findings for which the authors considered the evidence sufficiently consistent to warrant discussion.[1]</p>



<h3 class="wp-block-heading">Cytokine secretion in mice</h3>



<p class="wp-block-paragraph">The authors assessed the evidence for changes in cytokine secretion in mice as moderate.</p>



<p class="wp-block-paragraph">Cytokines are signalling proteins involved in regulating immune and inflammatory responses. Some studies reported changes following exposure to radiofrequency fields below the applicable ICNIRP exposure limits.</p>



<p class="wp-block-paragraph">However, the four studies contributing to this finding came from the same research group. Independent replication is therefore needed before firm conclusions can be drawn.</p>



<h3 class="wp-block-heading">Structural changes in the rat hippocampus</h3>



<p class="wp-block-paragraph">The authors assessed the evidence for structural changes in the hippocampus of rats as low.</p>



<p class="wp-block-paragraph">The hippocampus is a brain region involved in learning and memory. Some studies reported changes following exposure above ICNIRP limits, but the findings were inconsistent.</p>



<p class="wp-block-paragraph">Neither of these findings establishes that 5G exposure causes adverse health effects in humans.</p>



<h2 class="wp-block-heading">The thermal effect and higher frequencies</h2>



<p class="wp-block-paragraph">The review discusses the established thermal effects of radiofrequency exposure.</p>



<p class="wp-block-paragraph">The review states that, to date, the only scientifically accepted biological effect of RF-EMF at frequencies above 10 MHz is an increase in temperature caused by the absorption of electromagnetic energy by body tissues. This thermal mechanism forms the basis of current exposure limits recommended by organisations such as the International Commission on Non-Ionizing Radiation Protection (ICNIRP) and the Institute of Electrical and Electronics Engineers (IEEE).</p>



<p class="wp-block-paragraph">The authors also acknowledge that there is scientific and public debate about whether non-thermal effects may occur below these exposure limits, particularly following long-term exposure.[1]</p>



<p class="wp-block-paragraph">However, the review found that temperature-related effects were rarely investigated systematically in the experimental studies.</p>



<p class="wp-block-paragraph">Only five studies addressed thermoregulation or heat-related effects. Two rat studies, using frequencies of 26.5 and 28 GHz, reported effects at exposure levels above the applicable limits. Both came from the same research group, so independent confirmation is needed.[1]</p>



<p class="wp-block-paragraph">Higher radiofrequencies are absorbed more superficially than lower frequencies. Millimetre-wave energy is largely absorbed in the skin, meaning that deeper organs receive much less direct exposure.</p>



<p class="wp-block-paragraph">This makes research into possible effects on the skin and eyes particularly relevant as higher-frequency 5G systems are introduced.</p>



<p class="wp-block-paragraph">It also highlights the importance of investigating actual exposure conditions rather than assuming that findings at one frequency can automatically be applied to another.</p>



<h2 class="wp-block-heading">Do the studies reflect actual 5G exposure?</h2>



<p class="wp-block-paragraph">One of the most important limitations identified by the review concerns the relevance of the exposure signals used in the experiments.</p>



<p class="wp-block-paragraph">Among the 50 first- and second-tier studies included in the main evidence synthesis, only five explicitly stated that they investigated 5G.[1]</p>



<p class="wp-block-paragraph">However, the authors noted that even these five studies did not use typical 5G modulation patterns. Their signals were either continuous wave or GSM-like pulse-modulated signals. The remaining studies investigated therapeutic applications, high-power microwave exposures, radar signals or microwave exposures without focusing on a specific application.</p>



<p class="wp-block-paragraph">This matters because 5G is not defined by frequency alone.</p>



<p class="wp-block-paragraph">Signal characteristics, modulation, exposure duration and the way signals are transmitted all influence the exposure conditions. The review also notes that biological effects may depend on technical features such as beamforming and massive multiple-input multiple-output (MIMO) systems.</p>



<p class="wp-block-paragraph">Consequently, findings from experiments using older or substantially different signals cannot automatically be treated as representative of exposure to modern 5G networks.[1]</p>



<h2 class="wp-block-heading">What did the March 2026 search find?</h2>



<p class="wp-block-paragraph">The main evidence assessment was based on literature searches conducted in November 2022 and August 2023. To identify research published since then, the authors conducted an additional search of the EMF-Portal database on 18 March 2026.[1]</p>



<p class="wp-block-paragraph">This supplementary search identified 28 relevant articles: five human studies and 23 animal studies.[1]</p>



<p class="wp-block-paragraph">These articles were not subjected to the same detailed data extraction and risk-of-bias assessment as the original studies. They were therefore not incorporated into the main evidence synthesis.[1,2]</p>



<p class="wp-block-paragraph">Of these 28 studies:</p>



<ul class="wp-block-list">
<li>19 investigated frequencies at or below 6 GHz.</li>



<li>Five investigated frequencies between 24 and 28 GHz.</li>



<li>One covered both frequency ranges.</li>



<li>Three investigated frequencies between 9.3 and 10 GHz.[1]</li>
</ul>



<p class="wp-block-paragraph">Seventeen of the 28 studies explicitly referred to 5G, including all five human studies and 12 animal studies.[1]</p>



<p class="wp-block-paragraph">The 12 animal studies covered a range of topics, including brain and behavioural outcomes, male reproductive effects, offspring, eye effects, skin responses and stress biomarkers.[1]</p>



<p class="wp-block-paragraph">The supplementary material provides a reference list of these newly identified articles, allowing readers to examine the additional research themselves.[2]</p>



<h2 class="wp-block-heading">What about the five additional human studies?</h2>



<p class="wp-block-paragraph">The five human studies identified in the March 2026 supplementary search are worth examining individually because they provide some of the more recent experimental evidence involving 5G-relevant signals.</p>



<p class="wp-block-paragraph">Importantly, these studies were identified after the original evidence assessment and were not included in the review&#8217;s detailed risk-of-bias assessment.</p>



<h3 class="wp-block-heading">1. Jamal et al. (2024): Autonomous nervous system responses to environmental-level exposure to 5G&#8217;s first deployed band (3.5 GHz) in healthy human volunteers</h3>



<p class="wp-block-paragraph">This study involved 44 healthy young volunteers and investigated skin temperature and electrodermal activity during and after exposure to 3.5 GHz signals.</p>



<p class="wp-block-paragraph">The researchers used a randomised, crossover, triple-blind design, comparing real and sham exposure sessions. The electric field strength was 2 V/m at head level and 1.5 V/m at trunk level.</p>



<p class="wp-block-paragraph">The study found small changes in head and neck temperature and in certain electrodermal measurements. The authors noted that these changes remained within normal physiological ranges and could have been influenced by an uncontrolled factor.</p>



<p class="wp-block-paragraph">The findings are therefore preliminary and require further investigation.[3]</p>



<h3 class="wp-block-heading">2. Michelant et al. (2026): Brain electrical activity at 26 GHz</h3>



<p class="wp-block-paragraph">This randomised, triple-blind, crossover study involved 31 healthy young adults. Participants were exposed to 26 GHz radiofrequency fields for 26.5 minutes at an electric field strength of 2 V/m.</p>



<p class="wp-block-paragraph">The researchers examined brain electrical activity using electroencephalography (EEG).</p>



<p class="wp-block-paragraph">No significant changes were observed in the EEG measurements across the frequency bands or cortical regions investigated.[4]</p>



<h3 class="wp-block-heading">3. Michelant et al. (2026): Salivary stress biomarkers at 26 GHz</h3>



<p class="wp-block-paragraph">A separate study by Michelant and colleagues examined whether short-term exposure to 26 GHz affected salivary cortisol and alpha-amylase, two biomarkers associated with stress and autonomic nervous system activity.</p>



<p class="wp-block-paragraph">The study included 31 participants who underwent a triple-blind, randomised protocol involving 26.5 minutes of real or sham exposure. A subset of 16 participants also took part in an exploratory protocol involving cognitive testing and more frequent saliva sampling.</p>



<p class="wp-block-paragraph">The researchers found no significant differences in salivary cortisol or alpha-amylase between real and sham exposure conditions.[5]</p>



<p class="wp-block-paragraph">Both Michelant studies investigated short-term exposure to 26 GHz fields in groups of 31 participants. The publications describe closely related experimental protocols, so their findings should not be interpreted as evidence from two independent groups of 31 participants.</p>



<h3 class="wp-block-heading">4. Sousouri et al. (2025): Sleep EEG and genetic variation</h3>



<p class="wp-block-paragraph">This study involved 34 participants and investigated whether a particular genetic variant, CACNA1C rs7304986, influenced the effects of 5G radiofrequency exposure on sleep EEG activity.</p>



<p class="wp-block-paragraph">Participants underwent three experimental conditions: 700 MHz exposure, 3.6 GHz exposure and sham exposure. Each exposure lasted 30 minutes before sleep.</p>



<p class="wp-block-paragraph">The researchers reported a genotype-dependent change in sleep spindle centre frequency following 3.6 GHz exposure. The increase was observed in participants carrying the T/C variant, but not in the T/T group.</p>



<p class="wp-block-paragraph">Sleep spindles are patterns of brain activity that occur during non-rapid eye movement (NREM) sleep. The finding is a specific change in an EEG measure; it does not establish that exposure caused a sleep disorder or other adverse health effect.</p>



<p class="wp-block-paragraph">The result warrants further investigation and replication.[6]</p>



<h3 class="wp-block-heading">5. Torkan et al. (2025): Corticospinal and intracortical excitability</h3>



<p class="wp-block-paragraph">This randomised controlled pilot study involved 19 healthy adults. It investigated whether 3.6 GHz 5G mobile-phone exposure affected corticospinal excitability or intracortical mechanisms.</p>



<p class="wp-block-paragraph">Participants underwent exposure conditions lasting five and 20 minutes, as well as sham exposure. Measurements were taken before and after exposure using transcranial magnetic stimulation.</p>



<p class="wp-block-paragraph">The researchers found no statistically significant interaction between exposure condition and time for the measures investigated.</p>



<p class="wp-block-paragraph">However, the Bayesian analyses produced Bayes factors close to 1, indicating inconclusive evidence for either the presence or absence of an effect.</p>



<p class="wp-block-paragraph">It would therefore be inaccurate to interpret this study as demonstrating that 5G exposure has no effect. The results were inconclusive, and the authors recommended further research.[7]</p>



<h3 class="wp-block-heading">How should these five studies be interpreted?</h3>



<p class="wp-block-paragraph">The five studies do not provide a consistent picture of biological responses. Some reported small physiological changes or a genotype-dependent EEG finding, while others found no statistically significant changes in the outcomes examined.</p>



<p class="wp-block-paragraph">Three of the five human studies identified in the March 2026 supplementary search – Jamal et al. [3] and the two Michelant studies [4,5] – were associated with the GOLIAT research programme. Their findings therefore need independent confirmation.</p>



<p class="wp-block-paragraph">These were controlled, short-term experiments involving healthy volunteers. They were not designed to investigate long-term health outcomes or determine whether the findings apply to the wider population.</p>



<h2 class="wp-block-heading">Research published after the March 2026 search</h2>



<p class="wp-block-paragraph">Four additional human studies published during 2026 provide further information on physiological responses to 5G-relevant radiofrequency exposure. These studies appeared after the review&#8217;s supplementary literature search of 18 March 2026 and were therefore not included in its assessment.</p>



<p class="wp-block-paragraph">The studies investigated different biological endpoints following short-term exposure to 3.5 GHz and 26 GHz signals under controlled laboratory conditions.</p>



<h3 class="wp-block-heading">3.5 GHz exposure: Heart-rate variability and stress biomarkers</h3>



<p class="wp-block-paragraph">Jamal et al. (2026) investigated heart rate, heart-rate variability (HRV) and three salivary stress biomarkers: cortisol, alpha-amylase and chromogranin A. The study involved healthy young adults exposed to a 3.5 GHz signal.</p>



<p class="wp-block-paragraph">The researchers found no consistent exposure-related changes in HRV or the salivary biomarkers. One statistically significant interaction involving the HRV parameter RMSSD was observed, but it was small, limited to a single measurement period and not supported by other indicators. The authors therefore cautioned against interpreting it as evidence of a consistent physiological response.[8]</p>



<h3 class="wp-block-heading">26 GHz exposure: Skin temperature</h3>



<p class="wp-block-paragraph">Michelant et al. (2026) examined whether short-term exposure to 26 GHz radiofrequency signals affected skin temperature in 31 healthy young adults. Using infrared thermography, the researchers monitored temperature at several body sites during real and sham exposure sessions.</p>



<p class="wp-block-paragraph">No statistically significant differences in skin temperature were attributable to RF exposure. Temperature decreases observed at some sites occurred independently of exposure condition.[9]</p>



<h3 class="wp-block-heading">26 GHz exposure: Heart-rate variability</h3>



<p class="wp-block-paragraph">A second study by Michelant et al. (2026) investigated HRV responses in 31 healthy young adults exposed to 26 GHz signals.</p>



<p class="wp-block-paragraph">The main HRV measurements showed no statistically significant differences between real and sham exposure. Although an interaction was observed for one parameter, low-frequency power, subsequent analyses did not identify significant differences between exposure conditions or experimental phases. The researchers considered this finding inconclusive.[10]</p>



<h3 class="wp-block-heading">26 GHz exposure: Electrodermal activity</h3>



<p class="wp-block-paragraph">Michelant et al. (2026) also investigated electrodermal activity (EDA), which provides a measure of sympathetic nervous system activity, in healthy young adults.</p>



<p class="wp-block-paragraph">The researchers found no consistent exposure-related changes in electrodermal responses. An isolated difference in response latency was already present before exposure and did not vary with the experimental phase, making an association with 26 GHz exposure unlikely.[11]</p>



<h3 class="wp-block-heading">How should these additional findings be interpreted?</h3>



<p class="wp-block-paragraph">Taken together, the four papers did not demonstrate consistent acute physiological changes under the exposure conditions investigated. However, they add to the experimental evidence on biological responses to 5G-relevant frequencies and address endpoints that are not necessarily captured by conventional assessments of adverse health outcomes.</p>



<p class="wp-block-paragraph">All four studies arose from the GOLIAT research programme, which forms part of the European CLUE-H cluster.[8–12] Although they investigated different physiological endpoints, they should not be regarded as four independent replications. The three studies on heart-rate variability, salivary biomarkers and electrodermal activity came from the same controlled human exposure research programme.</p>



<p class="wp-block-paragraph">The studies involved healthy young adults and relatively short exposure periods. They therefore do not establish whether longer-term, repeated or cumulative exposure produces different responses, nor do they resolve questions about other populations or possible health outcomes.</p>



<p class="wp-block-paragraph">These findings should be considered alongside the wider body of experimental research rather than as a definitive assessment of the biological or health effects of 5G exposure.</p>



<h2 class="wp-block-heading">Limitations of the review</h2>



<p class="wp-block-paragraph">The authors acknowledge several limitations in their assessment.[1]</p>



<p class="wp-block-paragraph">The review was restricted to peer-reviewed studies published in English or German. Grey literature and studies published in other languages were not included.</p>



<p class="wp-block-paragraph">The review considered experimental studies involving humans and mammals, as well as epidemiological studies. In vitro studies, research involving non-mammalian species and studies deliberately examining combined exposure to RF-EMF and non-EMF factors were excluded.</p>



<p class="wp-block-paragraph">The application of ICNIRP exposure categories to animal studies also involves uncertainty. These limits are developed primarily with human exposure conditions in mind and cannot always be transferred directly to other species.</p>



<h3 class="wp-block-heading">What should happen next?</h3>



<p class="wp-block-paragraph">The review identifies several areas where further research is needed.[1]</p>



<p class="wp-block-paragraph">Important areas for further investigation include:</p>



<ul class="wp-block-list">
<li>Better-designed, high-quality experimental studies.</li>



<li>Adequate exposure characterisation and dosimetry.</li>



<li>Research into possible effects on the skin and eyes.</li>



<li>Studies using realistic 5G exposure scenarios and different field strengths.</li>



<li>Epidemiological studies that consider 5G separately, where possible, preferably cohort studies using improved exposure assessment based on objective, prospective data.</li>
</ul>



<p class="wp-block-paragraph">The distinction between biological effects and adverse health effects must remain central to future research. The absence of qualifying epidemiological evidence should not be interpreted as proof that long-term effects do not exist.</p>



<h2 class="wp-block-heading">Other research initiatives</h2>



<p class="wp-block-paragraph">Several European research projects have investigated questions relevant to 5G and radiofrequency exposure. ETAIN, GOLIAT, NextGEM and SEAWave are four projects within the European research cluster on electromagnetic fields and health, known as CLUE-H.[12]</p>



<p class="wp-block-paragraph">The projects address different aspects of radiofrequency exposure and health, including exposure assessment and possible effects on the skin.[13] They have different timelines. ETAIN and GOLIAT are both scheduled to run until 31 May 2027.[14,15] NextGEM’s scheduled project period ended on 30 June 2026,[16] while SEAWave’s ended on 30 November 2025.[17]</p>



<p class="wp-block-paragraph">These projects contribute to the broader research effort on electromagnetic fields and health. However, their work should not be confused with long-term epidemiological studies that examine health outcomes in populations over time.</p>



<h3 class="wp-block-heading">ANSES: A new research initiative in France</h3>



<p class="wp-block-paragraph">There are also signs of renewed research activity at national level. In 2026, the French Agency for Food, Environmental and Occupational Health and Safety (ANSES) announced a new research call entitled <em>Radiofrequencies and Health</em> under its National Research Programme for Environmental and Occupational Health.[18]</p>



<p class="wp-block-paragraph">The call covers frequencies from 8.3 kHz to 300 GHz and invites research into new exposure sources and signals, including connected devices, 5G, satellite technologies and different mobile communication modulations. It also allows projects to investigate radiofrequency fields in combination with other factors. The call places particular emphasis on methodological quality and research that can contribute to future expert assessments and public policy.</p>



<p class="wp-block-paragraph">The deadline for submitting letters of intent was 1 October 2026. Researchers whose proposals are selected at this first stage must submit their complete applications by 11 March 2027, at noon French time. This is an encouraging initiative, but it is a call for research proposals, not evidence that new studies have already begun. Nor does it guarantee that epidemiological studies will be funded. It does, however, recognise the need to address outstanding questions about radiofrequency exposure and health.</p>



<h3 class="wp-block-heading">References</h3>



<h4 class="wp-block-heading">Main review and supplementary material</h4>



<p class="wp-block-paragraph">[1] Bodewein L, Dechent D, Emonds T, Graefrath D, Keller AS, Krabbe J, et al. (2026).<em> Physiological and health-related effects of 5G-relevant radiofrequency fields: A systematic review of experimental studies in humans and mammals</em>. PLOS ONE, 21(11): e0361104. Published 4 November 2026.</p>



<p class="wp-block-paragraph"><a href="https://doi.org/10.1371/journal.pone.0361104?utm_source=chatgpt.com">https://doi.org/10.1371/journal.pone.0361104</a></p>



<p class="wp-block-paragraph">[2] Bodewein et al. (2026). Supporting Information S12: Reference List of newly identified articles.</p>



<p class="wp-block-paragraph"><a href="https://doi.org/10.1371/journal.pone.0361104.s012">https://doi.org/10.1371/journal.pone.0361104.s012</a></p>



<h4 class="wp-block-heading">Additional human studies identified in the March 2026 search</h4>



<p class="wp-block-paragraph">[3] Jamal L, Michelant L, Delanaud S, Hugueville L, Mazet P, Lévêque P, et al. (2024). Autonomous nervous system responses to environmental-level exposure to 5G’s first deployed band (3.5 GHz) in healthy human volunteers. <em>Experimental Physiology</em>, 109(12): 2122–2133.</p>



<p class="wp-block-paragraph"><a href="https://doi.org/10.1113/EP092083">https://doi.org/10.1113/EP092083</a></p>



<p class="wp-block-paragraph">[4] Michelant L, Baz T, Carrie A, Hugueville L, Lévêque P, Selmaoui B. (2026). Millimeter-wave high frequency 5G (26 GHz) electromagnetic fields do not modulate human brain electrical activity. <em>Environmental Research</em>, 289: 123349.</p>



<p class="wp-block-paragraph"><a href="https://doi.org/10.1016/j.envres.2025.123349">https://doi.org/10.1016/j.envres.2025.123349</a></p>



<p class="wp-block-paragraph">[5] Michelant L, Hugueville L, Lévêque P, Selmaoui B. (2026). No measurable impact of acute 26 GHz 5G exposure on salivary stress markers in healthy adults. <em>Environmental Research</em>, 290: 123439.</p>



<p class="wp-block-paragraph"><a href="https://doi.org/10.1016/j.envres.2025.123439">https://doi.org/10.1016/j.envres.2025.123439</a></p>



<p class="wp-block-paragraph">[6] Sousouri G, Eicher C, D&#8217;Angelo RM, Billecocq M, Fussinger T, Studler M, et al. (2025). 5G radio-frequency-electromagnetic-field effects on the human sleep electroencephalogram: A randomized controlled study in CACNA1C genotyped volunteers. <em>NeuroImage</em>, 317: 121340.</p>



<p class="wp-block-paragraph"><a href="https://doi.org/10.1016/j.neuroimage.2025.121340">https://doi.org/10.1016/j.neuroimage.2025.121340</a></p>



<p class="wp-block-paragraph">[7] Torkan A, et al. (2025). The Effect of 5G Mobile Phone Electromagnetic Exposure on Corticospinal and Intracortical Excitability in Healthy Adults: A Randomized Controlled Pilot Study. <em>Brain Sciences</em>, 15(11): 1134.</p>



<p class="wp-block-paragraph"><a href="https://doi.org/10.3390/brainsci15111134">https://doi.org/10.3390/brainsci15111134</a></p>



<h4 class="wp-block-heading">Additional research on 5G-relevant radiofrequency exposure (2026)</h4>



<p class="wp-block-paragraph">[8] Jamal L, Michelant L, Delanaud S, Bodin R, Hugueville L, Mazet P, Lévêque P, Baz T, Stephan-Blanchard E, Selmaoui B. (2026). Exposure to 5G Radiofrequency and Physiological Effects in Healthy Young Adults: Insights Into Heart Rate Variability and Salivary Stress Biomarkers. <em>Bioelectromagnetics</em>, 47(5): e70056.</p>



<p class="wp-block-paragraph"><a href="https://doi.org/10.1002/bem.70056">https://doi.org/10.1002/bem.70056</a></p>



<p class="wp-block-paragraph">[9] Michelant L, Delanaud S, Hugueville L, Lévêque P, Bach V, Tourneux P, Selmaoui B. (2026). No thermal skin effects at environmental 26 GHz field strengths relevant to 5G deployment. <em>Scientific Reports</em>, 16: 19461.</p>



<p class="wp-block-paragraph"><a href="https://doi.org/10.1038/s41598-026-49616-7">https://doi.org/10.1038/s41598-026-49616-7</a></p>



<p class="wp-block-paragraph">[10] Michelant L, Jamal L, Stephan-Blanchard E, Baz T, Leveille Nizerolle B, Hugueville L, Lévêque P, Selmaoui B. (2026). Heart rate variability responses to 26 GHz millimeter-wave exposure in healthy young adults. <em>Electromagnetic Biology and Medicine</em>. Published online 11 September 2026.</p>



<p class="wp-block-paragraph"><a href="https://doi.org/10.1080/15368378.2026.2730027">https://doi.org/10.1080/15368378.2026.2730027</a></p>



<p class="wp-block-paragraph">[11] Michelant L, Hugueville L, Lévêque P, Selmaoui B. (2026). Effects of 26 GHz radiofrequency exposure on electrodermal activity in healthy young adults. <em>International Journal of Radiation Biology</em>, 102(10): 1392–1401.</p>



<p class="wp-block-paragraph"><a href="https://doi.org/10.1080/09553002.2026.2678295">https://doi.org/10.1080/09553002.2026.2678295</a></p>



<h4 class="wp-block-heading">Research funding and calls</h4>



<p class="wp-block-paragraph">[12] European Commission. Cluster on Electromagnetic Fields Exposure and Health (CLUE-H). Official description of the four Horizon Europe projects and their collaboration.</p>



<p class="wp-block-paragraph"><a href="https://research-and-innovation.ec.europa.eu/research-area/health/environment-climate-and-health/clue-h_en">https://research-and-innovation.ec.europa.eu/research-area/health/environment-climate-and-health/clue-h_en</a></p>



<p class="wp-block-paragraph">[13] European Cluster on Electromagnetic Fields and Health (CLUE-H). Scientific Strategy of the Cluster. Further information about the research programme, including work on exposure assessment and skin-related effects.</p>



<p class="wp-block-paragraph"><a href="https://www.emf-health-cluster.eu/wp-content/uploads/2024/09/CLUE-H_ScientificStrategy.pdf">https://www.emf-health-cluster.eu/wp-content/uploads/2024/09/CLUE-H_ScientificStrategy.pdf</a></p>



<p class="wp-block-paragraph">[14] European Commission. Exposure To electromAgnetic fIelds and plaNetary health (ETAIN). CORDIS, Horizon Europe, Grant Agreement 101057216. Project period: 1 June 2022 – 31 May 2027.</p>



<p class="wp-block-paragraph"><a href="https://cordis.europa.eu/project/id/101057216">https://cordis.europa.eu/project/id/101057216</a></p>



<p class="wp-block-paragraph">[15] European Commission. 5G expOsure, causaL effects, and rIsk perception through citizen engAgemenT (GOLIAT). CORDIS, Horizon Europe, Grant Agreement 101057262. Project period: 1 June 2022 – 31 May 2027.</p>



<p class="wp-block-paragraph"><a href="https://cordis.europa.eu/project/id/101057262">https://cordis.europa.eu/project/id/101057262</a></p>



<p class="wp-block-paragraph">[16] European Commission. Next Generation Integrated Sensing and Analytical System for Monitoring and Assessing Radiofrequency Electromagnetic Field Exposure and Health (NextGEM). CORDIS, Horizon Europe, Grant Agreement 101057527. Project period: 1 July 2022 – 30 June 2026.</p>



<p class="wp-block-paragraph"><a href="https://cordis.europa.eu/project/id/101057527">https://cordis.europa.eu/project/id/101057527</a></p>



<p class="wp-block-paragraph">[17] European Commission. Scientific-Based Exposure and Risk Assessment of Radiofrequency and mm-Wave Systems from children to elderly (5G and Beyond) (SEAWave). CORDIS, Horizon Europe, Grant Agreement 101057622. Project period: 1 June 2022 – 30 November 2025.</p>



<p class="wp-block-paragraph"><a href="https://cordis.europa.eu/project/id/101057622">https://cordis.europa.eu/project/id/101057622</a></p>



<p class="wp-block-paragraph">[18] ANSES (2026). National Research Programme for Environmental and Occupational Health: Radiofrequencies and Health 2026 Call for Proposals.</p>



<p class="wp-block-paragraph"><a href="https://www.anses.fr/sites/default/files/GB-Texte_APREST_2026-RF.pdf">https://www.anses.fr/sites/default/files/GB-Texte_APREST_2026-RF.pdf</a></p>



<hr class="wp-block-separator has-alpha-channel-opacity"/>



<p class="wp-block-paragraph">This article discusses findings from published research. It does not claim that the reported biological effects establish adverse health outcomes or that the absence of statistically significant findings proves the absence of risk.</p>



<p class="wp-block-paragraph">EMFSA | 9 November 2026</p>



<p class="wp-block-paragraph"></p>
<p>The post <a href="https://www.emfsa.co.za/news/5g-and-health/">5G Scientific Evidence: Research Gaps in 2026</a> appeared first on <a href="https://www.emfsa.co.za">EMFSA</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>NTP Lite? How Lite Is It Really?</title>
		<link>https://www.emfsa.co.za/research-and-studies/ntp-lite-how-lite-is-it-really/</link>
		
		<dc:creator><![CDATA[Editor]]></dc:creator>
		<pubDate>Sat, 07 Nov 2026 07:02:48 +0000</pubDate>
				<category><![CDATA[Research and Studies]]></category>
		<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[National Toxicology Program (NTP)]]></category>
		<category><![CDATA[NTP Lite]]></category>
		<guid isPermaLink="false">https://www.emfsa.co.za/?p=33281</guid>

					<description><![CDATA[<p>NTP Lite? How Lite Is It Really? “NTP Lite” is an informal shorthand used to refer to two new animal studies from Japan and South Korea, published in 2026. Both studies reported no statistically significant increase in tumour incidence following long-term exposure to 900 MHz radiofrequency electromagnetic fields (RF-EMF).[1,2] Their findings are particularly relevant because [&#8230;]</p>
<p>The post <a href="https://www.emfsa.co.za/research-and-studies/ntp-lite-how-lite-is-it-really/">NTP Lite? How Lite Is It Really?</a> appeared first on <a href="https://www.emfsa.co.za">EMFSA</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<h1 class="wp-block-heading"><strong>NTP Lite? How Lite Is It Really?</strong></h1>



<figure class="wp-block-image size-full"><img decoding="async" width="521" height="282" src="https://www.emfsa.co.za/wp-content/uploads/2026/11/NTP-Lite.jpg" alt="NTP Lite? How Lite Is It Really? Two new animal studies. A closer look at the evidence." class="wp-image-33280" srcset="https://www.emfsa.co.za/wp-content/uploads/2026/11/NTP-Lite.jpg 521w, https://www.emfsa.co.za/wp-content/uploads/2026/11/NTP-Lite-300x162.jpg 300w" sizes="(max-width: 521px) 100vw, 521px" /></figure>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph">“NTP Lite” is an informal shorthand used to refer to two new animal studies from Japan and South Korea, published in 2026. Both studies reported no statistically significant increase in tumour incidence following long-term exposure to 900 MHz radiofrequency electromagnetic fields (RF-EMF).[1,2]</p>



<p class="wp-block-paragraph">Their findings are particularly relevant because an international re-evaluation of RF-EMF by the International Agency for Research on Cancer (IARC) has been recommended as a high priority for the 2025–2029 period.[3] Evidence from experimental animal studies will form part of that assessment.</p>



<p class="wp-block-paragraph">However, assessments by scientific and regulatory bodies in Switzerland, Germany and Australia have highlighted different aspects of the findings. While the studies have been welcomed as relevant new evidence, questions have also been raised about their design, statistical power and ability to investigate the tumour findings reported by the US National Toxicology Program (NTP) in 2018.</p>



<p class="wp-block-paragraph">How much can these new studies tell us? And are they sufficiently robust to investigate the findings that prompted the NTP&#8217;s conclusion of clear evidence of carcinogenic activity in male rats?[4]</p>



<h2 class="wp-block-heading"><strong>How Have Scientific and Regulatory Bodies Assessed the 2026 Studies?</strong></h2>



<h3 class="wp-block-heading"><strong>BERENIS – Swiss Expert Group on Electromagnetic Fields and Non-Ionising Radiation</strong></h3>



<p class="wp-block-paragraph">In its Newsletter No. 46 (October 2026), BERENIS assessed the two 2026 studies from Japan (Imaida et al.) and South Korea (Kim HS et al.) in relation to the 2018 NTP study.</p>



<p class="wp-block-paragraph">Its assessment focused on three main issues:</p>



<p class="wp-block-paragraph"><strong>Differences in exposure levels and study design</strong></p>



<p class="wp-block-paragraph">BERENIS highlighted important differences between the exposure levels and study designs of the 2026 studies and the NTP research. These are examined in more detail in the comparison section below.</p>



<p class="wp-block-paragraph"><strong>Survival differences</strong></p>



<p class="wp-block-paragraph">BERENIS raised concerns about the Japanese study’s interpretation of tumour findings in relation to differences in survival between the exposed and sham-exposed animals. We return to this issue when examining the survival data.</p>



<p class="wp-block-paragraph"><strong>Statistical power and rare tumours</strong></p>



<p class="wp-block-paragraph">BERENIS questioned whether the relatively small groups of animals in the 2026 studies provided sufficient statistical power to investigate the rare tumours identified in the NTP research. This issue is considered in more detail in the section on statistical power.</p>



<p class="wp-block-paragraph"><strong>BERENIS’s overall conclusion</strong></p>



<p class="wp-block-paragraph">BERENIS questioned whether the two studies could properly be regarded as replications of the NTP research. Its conclusion was explicit:</p>



<p class="wp-block-paragraph">“These studies never had the potential to verify the results of the NTP study, which, according to the authors, was one of the main aims.”</p>



<p class="wp-block-paragraph">It also noted that the publications made no mention of consultation with NTP researchers regarding study design, exposure or dosimetry.[5]</p>



<h3 class="wp-block-heading"><strong>BfS – Germany</strong></h3>



<p class="wp-block-paragraph">The German Federal Office for Radiation Protection (BfS) described the Japan–South Korea collaboration as a valuable approach, but cautioned that uncertainties remain.</p>



<p class="wp-block-paragraph">Neither study found a statistically significant increase in tumour incidence. However, when the results of the two studies were combined, the RF-exposed groups had three cardiac schwannomas and two brain gliomas, compared with one of each in the sham-exposed groups.</p>



<p class="wp-block-paragraph">BfS noted that the tumour findings in the two studies pointed in the same direction. However, the wide 95% confidence intervals and limited statistical power meant that the findings did not necessarily contradict the NTP results.[6]</p>



<p class="wp-block-paragraph">BfS also highlighted the differences in exposure levels and group sizes between the collaborative studies and the NTP research. It concluded that it remains uncertain whether statistically significant increases would have been detected had higher exposure levels and/or larger groups of animals been used.[6]</p>



<h3 class="wp-block-heading"><strong>ARPANSA – Australia</strong></h3>



<p class="wp-block-paragraph">The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) published its assessment of the Japanese and South Korean studies in January 2026. The webpage was subsequently reviewed on 25 February 2026.</p>



<p class="wp-block-paragraph">ARPANSA noted that the studies were conducted simultaneously but independently, using a common research protocol. Both followed Good Laboratory Practice and OECD guidelines. Neither study found a statistically significant increase in tumour incidence or evidence of DNA damage or chromosomal aberrations.</p>



<p class="wp-block-paragraph">ARPANSA concluded that the findings did not substantiate the earlier NTP results. It also noted that the tumour histopathology had undergone international peer review. This does not mean that ARPANSA&#8217;s own assessment was peer reviewed.[7]</p>



<h2 class="wp-block-heading"><strong>What Did the Original NTP Study Find?</strong></h2>



<p class="wp-block-paragraph">In male rats exposed to CDMA-modulated RF radiation, the NTP reported two findings of particular relevance.</p>



<p class="wp-block-paragraph"><strong>Malignant schwannomas of the heart</strong></p>



<p class="wp-block-paragraph">No malignant cardiac schwannomas occurred in the sham-control group. They were found in all three exposed groups:</p>



<ul class="wp-block-list">
<li>1.5 W/kg: 2 of 90 rats</li>



<li>3 W/kg: 3 of 90 rats</li>



<li>6 W/kg: 6 of 90 rats.[4]</li>
</ul>



<p class="wp-block-paragraph">The increase at 6 W/kg was statistically significant, as was the positive exposure-related trend.[4]</p>



<p class="wp-block-paragraph"><strong>Malignant gliomas of the brain</strong></p>



<p class="wp-block-paragraph">No malignant gliomas occurred in the sham-control group or the 1.5 and 3 W/kg groups. Three occurred in the 6 W/kg group. Although this increase was not statistically significant in the individual group comparison, the NTP considered the findings related to RF exposure.[4]</p>



<p class="wp-block-paragraph"><strong>The NTP&#8217;s conclusion</strong></p>



<p class="wp-block-paragraph">The NTP concluded that there was <em>clear evidence of carcinogenic activity</em> in male rats exposed to CDMA-modulated RF radiation.</p>



<ul class="wp-block-list">
<li>Cardiac schwannomas formed the basis for this conclusion.</li>



<li>Brain gliomas were also considered related to exposure, but did not form the basis for the clear evidence classification.[4]</li>
</ul>



<h2 class="wp-block-heading"><strong>How Do the 2026 Studies Compare with the NTP?</strong></h2>



<p class="wp-block-paragraph">Both 2026 studies used male Hsd:Sprague Dawley SD rats. Exposure began on gestational day 5 in the pregnant dams and continued after birth. At weaning, male offspring were selected for the two-year carcinogenicity study and continued to receive exposure until approximately 104 weeks of age.[1,2]</p>



<p class="wp-block-paragraph">The researchers used a 900 MHz CDMA-modulated RF signal at a whole-body specific absorption rate (SAR) of 4 W/kg. Exposure was delivered for 18 hours and 20 minutes per day in 10-minute on/off cycles.[1,2]</p>



<p class="wp-block-paragraph">The NTP study included both male and female rats and investigated GSM and CDMA signals at three whole-body SAR levels: 1.5, 3 and 6 W/kg. The 2026 studies included only male rats, investigated CDMA signals only, and used a single exposure level of 4 W/kg.[1,2,4]</p>



<p class="wp-block-paragraph">Using only one exposure level meant that the researchers could not examine a dose-response relationship. The 2026 studies also did not include the NTP&#8217;s highest exposure level of 6 W/kg, at which the statistically significant increase in malignant cardiac schwannomas was observed.[4]</p>



<p class="wp-block-paragraph">The group sizes were also smaller. For the two-year carcinogenicity phase, the researchers assigned 70 male rats to each group in both 2026 studies, compared with 90 animals per group in the NTP study.[1,2,4]</p>



<p class="wp-block-paragraph">These differences are important when considering whether the newer studies had sufficient statistical power to investigate the specific tumour findings reported by the NTP.</p>



<h2 class="wp-block-heading"><strong>Interpreting the Tumour Findings</strong></h2>



<h3 class="wp-block-heading">Controls and Survival</h3>



<p class="wp-block-paragraph">A control group is not simply a group in which nothing happens. It provides the baseline against which the exposed animals are assessed.</p>



<h4 class="wp-block-heading"><strong>Spontaneous tumours</strong></h4>



<p class="wp-block-paragraph">Rats can develop tumours without experimental exposure, particularly as they age. Some tumours, including cardiac schwannomas and brain gliomas, are rare.[1,4]</p>



<p class="wp-block-paragraph">The presence of tumours in a control group does not automatically mean that an exposure has no effect. Researchers compare tumour incidence in the exposed and control groups and also consider historical control data. These data show the range of tumour incidences observed in comparable animals in previous studies. They provide useful context, particularly for rare tumours, but do not replace the concurrent control group.[1,2,4]</p>



<h4 class="wp-block-heading"><strong>Sham controls and cage controls</strong></h4>



<p class="wp-block-paragraph">The 2026 studies included both sham-exposed and cage-control animals.[1,2]</p>



<p class="wp-block-paragraph">Sham-exposed animals underwent the same chamber procedures as the RF-exposed animals, but without active RF exposure. Cage-control animals remained under normal housing conditions and did not undergo the chamber exposure procedure.[1,2]</p>



<p class="wp-block-paragraph">Including both groups allowed researchers to compare the effects of RF exposure with those of the experimental procedures and normal housing conditions.</p>



<h4 class="wp-block-heading"><strong>Survival differences in the NTP study</strong></h4>



<p class="wp-block-paragraph">The male sham-control rats in the NTP study had substantially lower survival than the RF-exposed groups. For CDMA exposure, the estimated two-year survival probability was approximately 28% in the sham-control group, compared with 48%, 62% and 48% in the 1.5, 3 and 6 W/kg groups, respectively.[4]</p>



<p class="wp-block-paragraph">The NTP attributed the lower survival in the sham-control group largely to more severe chronic progressive nephropathy, a progressive kidney disease commonly found in ageing rats.[4]</p>



<p class="wp-block-paragraph">This matters because animals that survive longer have more opportunity to develop tumours, particularly those that occur later in life. The NTP therefore used statistical methods, including the Poly-3 test, to account for differences in survival when analysing tumour incidence.[4]</p>



<h4 class="wp-block-heading"><strong>Survival differences in the 2026 studies</strong></h4>



<p class="wp-block-paragraph">The Japanese study also reported a survival difference, but in the same direction as the NTP findings: more RF-exposed animals survived than sham controls.[1]</p>



<p class="wp-block-paragraph">At 105 weeks, 44 of 68 RF-exposed rats (64.7%) survived, compared with 30 of 70 sham-exposed rats (42.9%). In the cage-control group, 24 of 70 animals (34.3%) survived.[1] The higher survival in the RF-exposed group was statistically significant.[1]</p>



<p class="wp-block-paragraph">Two RF-exposed animals died at week 20 following equipment malfunction and were excluded from the survival analysis. This explains why the RF-exposed group had 68 animals available for the analysis, rather than 70.[1]</p>



<p class="wp-block-paragraph">The Japanese researchers used Peto&#8217;s test to analyse tumour incidence.[1] They also discussed the lower body weight and food consumption observed in the RF-exposed animals as possible factors associated with the survival difference.</p>



<p class="wp-block-paragraph">BERENIS criticised the Japanese authors&#8217; use of the survival difference to dismiss tumour findings generally, regardless of the direction in which those findings pointed.[5]</p>



<p class="wp-block-paragraph">The Korean study also included 70 animals initially in each of the three groups. At 104 weeks, survival was 58.6% in the RF-exposed and cage-control groups and 54.3% in the sham-exposed group. The researchers reported no statistically significant differences in survival between the three groups.[2]</p>



<h2 class="wp-block-heading"><strong>Does No Statistical Significance Mean There Is No Effect?</strong></h2>



<p class="wp-block-paragraph">A finding of no statistically significant increase in tumours does not necessarily mean that no increase occurred. It may also mean that a study did not have sufficient statistical power to detect an effect, particularly when the tumours being investigated are rare.</p>



<p class="wp-block-paragraph"><strong>Why statistical power matters</strong></p>



<p class="wp-block-paragraph">Statistical power refers to a study&#8217;s ability to detect an effect if one exists. The smaller the expected effect and the rarer the tumour, the more difficult it becomes to detect a difference between exposed and control animals.</p>



<p class="wp-block-paragraph"><strong>What does the 4.5% estimate tell us?</strong></p>



<p class="wp-block-paragraph">Based on the NTP findings, BERENIS estimated that the expected response for malignant cardiac schwannomas at 4 W/kg would be approximately 4.5%.[5]</p>



<p class="wp-block-paragraph">This was an estimate derived from the NTP findings; it was not an observed result in either of the 2026 studies. It illustrates how small the expected response might be and why detecting it would be difficult with relatively small groups of animals.</p>



<p class="wp-block-paragraph"><strong>What about a 20% increase?</strong></p>



<p class="wp-block-paragraph">BERENIS also drew attention to the Korean researchers&#8217; observation that an increase of around 20% in the incidence of cardiac schwannomas or malignant gliomas would not be readily detectable with the sample size used.[5]</p>



<p class="wp-block-paragraph">These considerations are important when assessing what the absence of statistically significant findings in the 2026 studies can tell us.</p>



<h2 class="wp-block-heading"><strong>What Do the 2026 Studies Tell Us?</strong></h2>



<p class="wp-block-paragraph">Taken together, the 2026 studies provide relevant new evidence, but they do not provide a definitive test of the NTP findings. Several points are important when interpreting their results:</p>



<ul class="wp-block-list">
<li><strong>The studies are relevant and should not be dismissed.</strong> They add to the scientific evidence on RF-EMF exposure and carcinogenicity.</li>



<li><strong>They did not reproduce the full NTP exposure design.</strong> They used a single exposure level of 4 W/kg, rather than the three exposure levels used by the NTP, including its highest level of 6 W/kg.</li>



<li><strong>Their statistical power was limited.</strong> The smaller groups of animals make it difficult to detect increases in rare tumours.</li>



<li><strong>They do not settle the question raised by the NTP study.</strong> The absence of statistically significant increases does not establish that the NTP findings have been disproved or that a smaller increase in tumour incidence can be ruled out.</li>
</ul>



<p class="wp-block-paragraph">EMFSA | 7 November 2026</p>



<h2 class="wp-block-heading"><strong>References</strong></h2>



<ol class="wp-block-list">
<li>Imaida K, et al. (2026). The International Collaborative Animal Study of mobile phone radiofrequency radiation carcinogenicity and genotoxicity: the Japanese study. <em>Toxicological Sciences</em>, 209(3), kfag002. <a href="https://doi.org/10.1093/toxsci/kfag002">https://doi.org/10.1093/toxsci/kfag002</a></li>



<li>Kim HS, et al. (2026). The International Collaborative Animal Study of the carcinogenicity and genotoxicity of mobile phone radiofrequency radiation: the Korean study. <em>Toxicological Sciences</em>, 209(3), kfag001. <a href="https://doi.org/10.1093/toxsci/kfag001">https://doi.org/10.1093/toxsci/kfag001</a></li>



<li>International Agency for Research on Cancer (IARC). (2024). <em>Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2025–2029.</em> <a href="https://monographs.iarc.who.int/wp-content/uploads/2024/11/AGP_Report_2025-2029.pdf">Read report (PDF)</a></li>



<li>National Toxicology Program (NTP). (2018).<em> Toxicology and Carcinogenesis Studies in Hsd:Sprague Dawley SD Rats Exposed to Whole-Body Radio Frequency Radiation at a Frequency (900 MHz) and Modulations (GSM and CDMA) Used by Cell Phones. NTP Technical Report 595</em>. <a href="https://ntp.niehs.nih.gov/sites/default/files/ntp/htdocs/lt_rpts/tr595_508.pdf">Read report (PDF)</a></li>



<li>BERENIS. (October 2026). <em>Newsletter No. 46.</em> Swiss Expert Group on Electromagnetic Fields and Non-Ionising Radiation. <a href="https://www.bafu.admin.ch/dam/en/sd-web/GNj61B5HPFQZ/Newsletter_BERENIS_Nr46_oct_2026_EN.pdf">Read newsletter (PDF)</a></li>



<li>Federal Office for Radiation Protection (BfS), Competence Centre for Electromagnetic Fields (KEMF). (2026). <em>Spotlight on “The international collaborative animal study of the carcinogenicity and genotoxicity of mobile phone radiofrequency radiation” by Imaida et al. (Japanese study) and Kim et al. (Korean study) in Toxicological Sciences (2026).</em> Spotlight – Jun/2026 No. 1 (Eng). URN: urn:nbn:de:0221-2026061660652.</li>



<li>Australian Radiation Protection and Nuclear Safety Agency (ARPANSA). (January 2026; webpage reviewed 25 February 2026). <em>Korean and Japanese studies agree that radiofrequency exposure does not cause cancer in rats.</em> <a href="https://www.arpansa.gov.au/korean-and-japanese-studies-agree-radiofrequency-exposure-does-not-cause-cancer-rats">Read ARPANSA assessment</a></li>
</ol>
<p>The post <a href="https://www.emfsa.co.za/research-and-studies/ntp-lite-how-lite-is-it-really/">NTP Lite? How Lite Is It Really?</a> appeared first on <a href="https://www.emfsa.co.za">EMFSA</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Non-Ionizing Radiation: Unanswered Questions</title>
		<link>https://www.emfsa.co.za/news/non-ionizing-radiation-unanswered-questions/</link>
		
		<dc:creator><![CDATA[Editor]]></dc:creator>
		<pubDate>Fri, 30 Oct 2026 11:47:50 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Compliance]]></category>
		<category><![CDATA[FCC]]></category>
		<category><![CDATA[HHS]]></category>
		<category><![CDATA[Non Ionizing Radiation]]></category>
		<category><![CDATA[Standards]]></category>
		<guid isPermaLink="false">https://www.emfsa.co.za/?p=33254</guid>

					<description><![CDATA[<p>Non-Ionizing Radiation: Unanswered Questions Non-ionizing radiation is the subject of ongoing scientific research, regulatory review and public discussion. Legal, Regulatory, Scientific and Technical Perspectives The October EMFSA update explores these questions through four topics covering recent legal, regulatory, scientific and technical developments. Four topics to explore Mobile Phone Radiation Litigation EU Decision 2026/2003: RF-EMF Exposure [&#8230;]</p>
<p>The post <a href="https://www.emfsa.co.za/news/non-ionizing-radiation-unanswered-questions/">Non-Ionizing Radiation: Unanswered Questions</a> appeared first on <a href="https://www.emfsa.co.za">EMFSA</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<h1 class="wp-block-heading">Non-Ionizing Radiation: Unanswered Questions</h1>



<p class="wp-block-paragraph">Non-ionizing radiation is the subject of ongoing scientific research, regulatory review and public discussion. </p>



<p class="wp-block-paragraph"><em>Legal, Regulatory, Scientific and Technical Perspectives</em></p>



<ul class="wp-block-list">
<li>How should we interpret legal decisions involving radiofrequency (RF) exposure?</li>



<li>How do technical standards guide the measurement and assessment of exposure?</li>



<li>Do compliance tests reflect the configurations people use in everyday life? </li>



<li>What role can scientists play in regulatory discussions and the development of exposure policies?</li>
</ul>



<p class="wp-block-paragraph">The October EMFSA update explores these questions through four topics covering recent legal, regulatory, scientific and technical developments.</p>



<p class="wp-block-paragraph"><strong>Four topics to explore</strong></p>



<h3 class="wp-block-heading"><strong><a href="https://www.emfsa.co.za/news/legal/mobile-phone-radiation-litigation/">Mobile Phone Radiation Litigation</a></strong></h3>



<figure class="wp-block-image size-full"><img decoding="async" width="483" height="182" src="https://www.emfsa.co.za/wp-content/uploads/2026/10/Mobile-Phone-Litigation.jpg" alt="Mobile Phone Radiation Litigation — court cases, legal claims and occupational health." class="wp-image-32936" srcset="https://www.emfsa.co.za/wp-content/uploads/2026/10/Mobile-Phone-Litigation.jpg 483w, https://www.emfsa.co.za/wp-content/uploads/2026/10/Mobile-Phone-Litigation-300x113.jpg 300w" sizes="(max-width: 483px) 100vw, 483px" /></figure>



<ul class="wp-block-list">
<li>What have courts in different countries decided in cases involving mobile phone radiation?</li>



<li>What can individual case outcomes establish, and where are the limits of those findings?</li>
</ul>



<h3 class="wp-block-heading"><strong><a href="https://www.emfsa.co.za/safety/eu-decision-2026-2003-rf-emf-exposure/">EU Decision 2026/2003: RF-EMF Exposure</a></strong></h3>



<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="515" height="281" src="https://www.emfsa.co.za/wp-content/uploads/2026/10/RF-Exposure-Compliance.jpg" alt="Graphic titled “RF-Exposure Compliance” explaining what a test result establishes and what it does not." class="wp-image-32900" srcset="https://www.emfsa.co.za/wp-content/uploads/2026/10/RF-Exposure-Compliance.jpg 515w, https://www.emfsa.co.za/wp-content/uploads/2026/10/RF-Exposure-Compliance-300x164.jpg 300w" sizes="auto, (max-width: 515px) 100vw, 515px" /></figure>



<ul class="wp-block-list">
<li>What does the latest EU decision mean for harmonised standards, SAR measurement and the assessment of RF-EMF exposure? </li>



<li>How should compliance results be interpreted?</li>
</ul>



<h3 class="wp-block-heading"><strong><a href="https://www.emfsa.co.za/safety/metal-components-in-body-worn-accessories/">Metal Components in Body-Worn Accessories</a></strong></h3>



<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="960" height="540" src="https://www.emfsa.co.za/wp-content/uploads/2026/10/Metal-Components-in-Body-Worn-Accessories.jpg" alt="Title graphic reading Metal Components in Body-Worn Accessories" class="wp-image-32651" style="width:363px;height:auto" srcset="https://www.emfsa.co.za/wp-content/uploads/2026/10/Metal-Components-in-Body-Worn-Accessories.jpg 960w, https://www.emfsa.co.za/wp-content/uploads/2026/10/Metal-Components-in-Body-Worn-Accessories-300x169.jpg 300w, https://www.emfsa.co.za/wp-content/uploads/2026/10/Metal-Components-in-Body-Worn-Accessories-768x432.jpg 768w" sizes="auto, (max-width: 960px) 100vw, 960px" /></figure>



<ul class="wp-block-list">
<li>Why do some smartphone manufacturers caution against accessories containing metal? </li>



<li>Could changes to a phone&#8217;s tested configuration affect its compliance assessment?</li>
</ul>



<h3 class="wp-block-heading"><strong><a href="https://www.emfsa.co.za/research-and-studies/hhs-and-fcc-rfi-submissions/">HHS and FCC RFI Submissions</a></strong></h3>



<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="523" height="281" src="https://www.emfsa.co.za/wp-content/uploads/2026/10/HHS-and-FCC-RFI-Submissions.jpg" alt="Two public submissions to HHS on electromagnetic fields and wireless radiation, and to the FCC on radiofrequency exposure limits and policies." class="wp-image-33229" srcset="https://www.emfsa.co.za/wp-content/uploads/2026/10/HHS-and-FCC-RFI-Submissions.jpg 523w, https://www.emfsa.co.za/wp-content/uploads/2026/10/HHS-and-FCC-RFI-Submissions-300x161.jpg 300w" sizes="auto, (max-width: 523px) 100vw, 523px" /></figure>



<ul class="wp-block-list">
<li>What issues have scientists raised in response to U.S. government requests for information on electromagnetic fields and RF radiation? </li>



<li>What role can independent scientific contributions play in regulatory discussions?</li>
</ul>



<p class="wp-block-paragraph">Taken together, these topics highlight an important consideration: understanding non-ionizing radiation requires more than looking at exposure limits or individual research findings in isolation. Legal decisions, measurement methods, technical standards and scientific evidence all contribute to the wider discussion.</p>



<p class="wp-block-paragraph"><strong>Explore the October EMFSA update and read more about these developments.</strong></p>



<p class="wp-block-paragraph">[<a href="https://mailchi.mp/emfsa/emfsa-october-2026-newsletter">READ THE OCTOBER EMFSA UPDATE</a>]</p>



<p class="wp-block-paragraph">EMFSA | 30 October</p>



<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="595" height="209" src="https://www.emfsa.co.za/wp-content/uploads/2026/06/EMFSA-LOGO-1.jpg" alt="Electromagnetic Fields South Africa (EMFSA) logo in white and green letters on a background depicting telecommunication systems" class="wp-image-31211" style="aspect-ratio:2.8471028037383177;width:320px;height:auto" srcset="https://www.emfsa.co.za/wp-content/uploads/2026/06/EMFSA-LOGO-1.jpg 595w, https://www.emfsa.co.za/wp-content/uploads/2026/06/EMFSA-LOGO-1-300x105.jpg 300w" sizes="auto, (max-width: 595px) 100vw, 595px" /><figcaption class="wp-element-caption">Electromagnetic Fields South Africa (EMFSA) logo</figcaption></figure>
<p>The post <a href="https://www.emfsa.co.za/news/non-ionizing-radiation-unanswered-questions/">Non-Ionizing Radiation: Unanswered Questions</a> appeared first on <a href="https://www.emfsa.co.za">EMFSA</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>HHS and FCC RFI Submissions</title>
		<link>https://www.emfsa.co.za/research-and-studies/hhs-and-fcc-rfi-submissions/</link>
		
		<dc:creator><![CDATA[Editor]]></dc:creator>
		<pubDate>Fri, 30 Oct 2026 08:43:16 +0000</pubDate>
				<category><![CDATA[Research and Studies]]></category>
		<category><![CDATA[Environment]]></category>
		<category><![CDATA[FCC]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[RFI]]></category>
		<category><![CDATA[US HHS]]></category>
		<guid isPermaLink="false">https://www.emfsa.co.za/?p=33228</guid>

					<description><![CDATA[<p>HHS and FCC RFI Submissions The HHS and FCC RFI Submissions relate to two U.S. government requests for information concerning electromagnetic fields (EMFs) and radiofrequency (RF) radiation. The U.S. Department of Health and Human Services (HHS) sought public input on EMFs and wireless radiation exposure. Separately, the Federal Communications Commission (FCC) invited comments in connection [&#8230;]</p>
<p>The post <a href="https://www.emfsa.co.za/research-and-studies/hhs-and-fcc-rfi-submissions/">HHS and FCC RFI Submissions</a> appeared first on <a href="https://www.emfsa.co.za">EMFSA</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<h1 class="wp-block-heading">HHS and FCC RFI Submissions</h1>



<p class="wp-block-paragraph">The HHS and FCC RFI Submissions relate to two U.S. government requests for information concerning electromagnetic fields (EMFs) and radiofrequency (RF) radiation. The U.S. Department of Health and Human Services (HHS) sought public input on EMFs and wireless radiation exposure. Separately, the Federal Communications Commission (FCC) invited comments in connection with its reassessment of RF exposure limits and policies, following a court remand in Environmental Health Trust v. FCC (2021).</p>



<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="523" height="281" src="https://www.emfsa.co.za/wp-content/uploads/2026/10/HHS-and-FCC-RFI-Submissions.jpg" alt="Two public submissions to HHS on electromagnetic fields and wireless radiation, and to the FCC on radiofrequency exposure limits and policies." class="wp-image-33229" srcset="https://www.emfsa.co.za/wp-content/uploads/2026/10/HHS-and-FCC-RFI-Submissions.jpg 523w, https://www.emfsa.co.za/wp-content/uploads/2026/10/HHS-and-FCC-RFI-Submissions-300x161.jpg 300w" sizes="auto, (max-width: 523px) 100vw, 523px" /><figcaption class="wp-element-caption"><br></figcaption></figure>



<p class="wp-block-paragraph">This post presents James Chrystopher Lech’s two submissions, which address different aspects of RF exposure, including research, measurement and assessment.</p>



<h3 class="wp-block-heading"><strong>1. Submission to the U.S. Department of Health and Human Services (HHS)</strong></h3>



<p class="wp-block-paragraph"><strong>Request for Information on Electromagnetic Fields (EMFs), Radiofrequency (RF) Radiation, and Wireless Radiation Exposure</strong></p>



<p class="wp-block-paragraph"><strong>Docket No.:</strong> HHS-OASH-2026-0397<br><strong>Comment by:</strong> James Chrystopher Lech<br><strong>Date:</strong> 30 September 2026</p>



<p class="wp-block-paragraph">The comment addresses the HHS request for information from the perspective of an independent scientist who submitted South Africa’s national reports to the WHO International EMF Project for 2021 and 2022.</p>



<p class="wp-block-paragraph">Its topics include exposure characterisation, a proposed “light-first envelope”, the importance of considering exposure configurations rather than relying on a single numerical limit, and an offer to brief on the simulation of combined exposures.</p>



<p class="wp-block-paragraph">The submission also refers to professional engagement with Dr Rune Floberghagen of the European Space Agency, Prof. László G. Boros, Dr Stephanie Seneff and former U.S. Ambassador Claire A. Pierangelo, as well as the Dutch Hacking Health Award. The submission cites related correspondence and supporting documents, which are not attached to the comment.</p>



<p class="wp-block-paragraph"><a href="https://www.regulations.gov/comment/HHS-OASH-2026-0397-1165">View the HHS submission on Regulations.gov</a> |&nbsp;<a href="https://www.emfsa.co.za/wp-content/uploads/2026/10/HHS-OASH-2026-0397-1165_attachment_1-1.pdf">HHS submission (PDF)</a></p>



<h3 class="wp-block-heading"><strong>2. Submission to the Federal Communications Commission (FCC)</strong></h3>



<p class="wp-block-paragraph"><strong>In the Matter of Reassessment of Federal Communications Commission Radiofrequency Exposure Limits and Policies</strong></p>



<p class="wp-block-paragraph"><strong>Docket:</strong> FCC ET Docket No. 13-84<br><strong>FCC document:</strong> DA 26-997<br><strong>Comment by:</strong> James Chrystopher Lech<br><strong>Date:</strong> 30 September 2026</p>



<p class="wp-block-paragraph">The FCC submission addresses the six issues remanded in <em>Environmental Health Trust v. FCC</em> (2021), as framed in DA 26-997:</p>



<ul class="wp-block-list">
<li>Portable-device testing procedures</li>



<li>Children</li>



<li>Long-term exposure</li>



<li>The ubiquity of wireless devices</li>



<li>Technological changes since 1996</li>



<li>Environmental effects</li>
</ul>



<p class="wp-block-paragraph">The comment identifies Lech as an independent scientist and outlines his background in non-ionising radiation research, reporting for the WHO International EMF Project, selected research publications and applied research projects. It also refers to professional correspondence concerning research methods and exposure assessment.</p>



<p class="wp-block-paragraph">The comment states that it addresses only the six issues remanded to the FCC and does not ask the Commission to relitigate matters the court left undisturbed.&nbsp;</p>



<p class="wp-block-paragraph">&nbsp;<a href="https://www.fcc.gov/ecfs/document/26110078866/1">Read James Chrystopher Lech’s FCC submission</a></p>



<h3 class="wp-block-heading"><strong>Institutional disclaimer</strong></h3>



<p class="wp-block-paragraph">The submissions state that they were not made on behalf of the World Health Organization (WHO), the South African National Defence Force (SANDF), the European Space Agency (ESA), the South African National Research Foundation (NRF), the International Commission on Non-Ionizing Radiation Protection (ICNIRP), Vrije Universiteit Amsterdam, or any government. The FCC submission also states that it was not made on behalf of FCC peer agencies.</p>



<h3 class="wp-block-heading">Access to Public Submissions</h3>



<p class="wp-block-paragraph">Public submissions to both requests for information can be accessed free of charge through the official U.S. government websites. The records include submissions from scientists, researchers, organisations and other interested parties, allowing readers to explore a range of perspectives.</p>



<ul class="wp-block-list">
<li><strong>HHS:</strong> <a href="https://www.regulations.gov/docket/HHS-OASH-2026-0397">View public comments and documents in Docket HHS-OASH-2026-0397 on Regulations.gov</a></li>



<li><strong>FCC:</strong> <a href="https://www.fcc.gov/ecfs">Search public filings in the FCC Electronic Comment Filing System (ECFS)</a>. Search for <strong>ET Docket No. 13-84</strong> to find filings relating to the reassessment of radiofrequency exposure limits and policies.</li>
</ul>



<p class="wp-block-paragraph">Related: <a href="https://www.emfsa.co.za/news/electromagnetic-fields-and-radiofrequency-radiation-u-s-hhs-seeks-public-input-france-calls-for-new-research/">Electromagnetic Fields and Radiofrequency Radiation: U.S. HHS Seeks Public Input; France Calls for New Research</a></p>



<p class="wp-block-paragraph"></p>
<p>The post <a href="https://www.emfsa.co.za/research-and-studies/hhs-and-fcc-rfi-submissions/">HHS and FCC RFI Submissions</a> appeared first on <a href="https://www.emfsa.co.za">EMFSA</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Mobile Phone Radiation Litigation</title>
		<link>https://www.emfsa.co.za/news/legal/mobile-phone-radiation-litigation/</link>
		
		<dc:creator><![CDATA[Editor]]></dc:creator>
		<pubDate>Wed, 28 Oct 2026 20:09:15 +0000</pubDate>
				<category><![CDATA[Legal]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Litigation]]></category>
		<category><![CDATA[Mobile phone radiation]]></category>
		<guid isPermaLink="false">https://www.emfsa.co.za/?p=32937</guid>

					<description><![CDATA[<p>Mobile Phone Radiation Litigation Mobile phone radiation litigation has involved manufacturers, employers, occupational compensation authorities and regulatory institutions in several countries. The proceedings have addressed different questions, including alleged product-safety failures, consumer information, occupational health, the admissibility of scientific evidence and access to regulatory documents. This article examines selected cases and legal developments, outlining the [&#8230;]</p>
<p>The post <a href="https://www.emfsa.co.za/news/legal/mobile-phone-radiation-litigation/">Mobile Phone Radiation Litigation</a> appeared first on <a href="https://www.emfsa.co.za">EMFSA</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<h1 class="wp-block-heading">Mobile Phone Radiation Litigation</h1>



<p class="wp-block-paragraph">Mobile phone radiation litigation has involved manufacturers, employers, occupational compensation authorities and regulatory institutions in several countries. The proceedings have addressed different questions, including alleged product-safety failures, consumer information, occupational health, the admissibility of scientific evidence and access to regulatory documents.</p>



<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="483" height="182" src="https://www.emfsa.co.za/wp-content/uploads/2026/10/Mobile-Phone-Litigation.jpg" alt="Mobile Phone Radiation Litigation — court cases, legal claims and occupational health." class="wp-image-32936" srcset="https://www.emfsa.co.za/wp-content/uploads/2026/10/Mobile-Phone-Litigation.jpg 483w, https://www.emfsa.co.za/wp-content/uploads/2026/10/Mobile-Phone-Litigation-300x113.jpg 300w" sizes="auto, (max-width: 483px) 100vw, 483px" /></figure>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph">This article examines selected cases and legal developments, outlining the allegations, relevant court decisions and reported procedural outcomes. It distinguishes claims made by the parties from judicial findings and identifies where the available information does not establish a case’s final status.</p>



<h2 class="wp-block-heading"><strong>Claims Against Manufacturers</strong></h2>



<h3 class="wp-block-heading"><strong>1. In re Wireless Telephone Radio Frequency Emissions Products Liability Litigation</strong></h3>



<p class="wp-block-paragraph"><strong>United States | 2001–2006 | Consolidated proceedings involving five class actions</strong></p>



<p class="wp-block-paragraph"><strong>Issue</strong>: Could mobile phone manufacturers face state-law claims over alleged health risks associated with radiofrequency (RF) emissions?</p>



<p class="wp-block-paragraph">Five class actions were filed in different states. The court consolidated the cases for pretrial proceedings in a federal court in Maryland.</p>



<p class="wp-block-paragraph"> The plaintiffs alleged that RF emissions from mobile phones posed health risks and that manufacturers had failed to provide adequate protection or warnings.</p>



<p class="wp-block-paragraph">In 2003, the federal district court dismissed the five cases on the basis of implied conflict pre-emption. This doctrine can prevent state-law claims from proceeding where they conflict with federal law or its regulatory objectives.</p>



<p class="wp-block-paragraph">In 2005, the U.S. Court of Appeals for the Fourth Circuit held that federal courts lacked subject-matter jurisdiction over four cases—Pinney, Farina, Gilliam and Gimpelson—and returned them to state courts. In the fifth case, Naquin, the court reversed the dismissal on pre-emption grounds and sent the case back for further proceedings.[1]</p>



<p class="wp-block-paragraph">The subsequent procedural histories differed. Motorola’s 2006 Form 10-K reports that the plaintiffs dismissed Pinney without prejudice in April 2006 and Gilliam without prejudice in March 2006. The report also records that the Naquin plaintiffs dismissed their case without prejudice on 6 November 2006.[2] Motorola’s 2005 Annual Report records that the Gimpelson plaintiff dismissed that case without prejudice on 30 January 2006.[3] Farina continued separately, as discussed below.</p>



<p class="wp-block-paragraph">These proceedings illustrate the distinction between a federal court’s authority to hear a case and the effect of federal law on particular state-law claims. The cases followed different procedural paths, and the appellate decision did not establish that mobile phone RF emissions cause or do not cause adverse health effects.</p>



<h3 class="wp-block-heading"><strong>2. Farina v. Nokia Inc.</strong></h3>



<p class="wp-block-paragraph"><strong>United States | 2001–2011 | Putative class action</strong></p>



<p class="wp-block-paragraph"><strong>Issue</strong>: Did manufacturers fail to provide adequate protection or warnings about RF exposure from mobile phones, in violation of state law?</p>



<p class="wp-block-paragraph">Francis J. Farina filed a putative class action in 2001, alleging that mobile phones were unsafe to use next to the head without headsets because of RF exposure. His claims included alleged breaches of warranty and violations of Pennsylvania consumer-protection law.</p>



<p class="wp-block-paragraph">The federal multidistrict litigation initially included this case. In 2005, the Fourth Circuit declined to rule on the merits of the pre-emption defence to Farina’s claims because it lacked jurisdiction. The court directed the parties to return the case to Pennsylvania state court. The court’s separate pre-emption ruling in that appeal concerned Naquin, not Farina.[1]</p>



<p class="wp-block-paragraph">In a subsequent appeal, the U.S. Court of Appeals for the Third Circuit affirmed the dismissal of Farina’s amended complaint on 22 October 2010. The Third Circuit held that federal law pre-empted the claims because allowing a jury to find FCC-compliant phones unsafe on the basis alleged would conflict with the objectives of the federal regulatory framework.[4]</p>



<p class="wp-block-paragraph">The U.S. Supreme Court declined to review the decision on 3 October 2011.<strong>[</strong>5<strong>]</strong></p>



<p class="wp-block-paragraph">The case illustrates how federal regulation can limit certain state-law product-safety and consumer-protection claims against mobile phone manufacturers. The decisions addressed jurisdiction and legal pre-emption; they did not constitute a comprehensive scientific determination of the health effects of RF exposure.</p>



<h3 class="wp-block-heading"><strong>3. Cohen v. Apple Inc.</strong></h3>



<p class="wp-block-paragraph"><strong>United States | 2022 | Product-safety and consumer-protection claims</strong></p>



<p class="wp-block-paragraph"><strong>Issue:</strong> Whether Apple could be held liable for allegedly misrepresenting or failing to disclose the RF emissions of its iPhones.</p>



<p class="wp-block-paragraph">A group of iPhone users alleged that Apple misrepresented or failed to disclose the phones’ RF emissions, including allegations that the devices exceeded the applicable federal exposure limit. The plaintiffs brought claims under state tort and consumer-protection laws.</p>



<p class="wp-block-paragraph">On 26 August 2022, the U.S. Court of Appeals for the Ninth Circuit upheld summary judgment for Apple, holding that federal law pre-empted the state-law claims. On appeal, the plaintiffs conceded that the iPhones complied with the FCC’s RF exposure limits but argued that the devices could still be unsafe despite that compliance. The court held that federal law pre-empted state-law claims seeking to impose liability based on RF emissions below the levels permitted by the FCC.[6]</p>



<h3 class="wp-block-heading"><strong>4. Murray v. Motorola, Inc., and Related Proceedings</strong></h3>



<p class="wp-block-paragraph"><strong>United States | Litigation beginning in 2001; appellate decisions in 2025 and 2026 | Consolidated personal-injury claims</strong></p>



<p class="wp-block-paragraph"><strong>Issue:</strong> Whether long-term mobile phone use caused brain tumours or brain cancer, as alleged by plaintiffs and the estates of people who had died from brain cancer.</p>



<p class="wp-block-paragraph">The litigation began in 2001 and involved multiple appeals. The plaintiffs alleged that long-term exposure to mobile phone radiation had caused brain tumours, including gliomas and acoustic neuromas.</p>



<p class="wp-block-paragraph">In earlier proceedings, the D.C. Court of Appeals held that federal law did not completely pre-empt the claims.[7] In a subsequent decision in 2016, the court adopted the Daubert standard for assessing the admissibility of expert testimony and remanded the litigation for further proceedings.[8]</p>



<p class="wp-block-paragraph">On 17 July 2025, the D.C. Court of Appeals affirmed the exclusion of the plaintiffs’ expert testimony on general causation and the resulting summary judgment for Motorola and other telecommunications defendants. The appeal concerned 13 consolidated cases. The court also upheld the trial judges’ case-management and discovery decisions.[9]</p>



<p class="wp-block-paragraph">The court concluded that the plaintiffs had not presented admissible expert evidence sufficient to establish general causation—that mobile phone radiation could cause the relevant types of brain tumours.</p>



<h4 class="wp-block-heading">Brooks v. Mitsubishi Electric &amp; Electronics USA, Inc. (2026)</h4>



<p class="wp-block-paragraph">In a related development, the D.C. Court of Appeals upheld summary judgment for the cellphone companies on 16 July 2026. The majority held that the Brooks plaintiffs had agreed to be bound by the <em>Murray</em> ruling on the admissibility of expert evidence concerning general causation and by the procedural rulings leading to that decision. Because the <em>Murray</em> plaintiffs’ expert testimony had been excluded and the Brooks plaintiffs lacked the required admissible expert evidence, the court upheld summary judgment against them. Senior Judge Thompson dissented, arguing that the Brooks plaintiffs had not agreed to be bound by the <em>Murray</em> case-management arrangements and should have been allowed to conduct their own discovery and present their own experts.[10]</p>



<p class="wp-block-paragraph"><strong>Case status:</strong> On 27 August 2026, the D.C. Court of Appeals issued its mandate following its 16 July 2026 decision affirming summary judgment for the cellphone-company defendants. The official docket lists no pending post-decision matter or further scheduled action as of 28 October 2026.</p>



<h3 class="wp-block-heading"><strong>5. Briganti v. Apple Distribution International Ltd.</strong></h3>



<p class="wp-block-paragraph"><strong>Italy | 2026 | Consumer information and product safety | Remitted for reconsideration</strong></p>



<p class="wp-block-paragraph"><strong>Issue:</strong> Whether a mobile phone manufacturer adequately informed a consumer about potential health risks associated with prolonged RF exposure and measures that could reduce exposure.</p>



<p class="wp-block-paragraph">The claimant alleged that she had not received adequate information about potential health risks associated with prolonged RF exposure from her iPhone SE or about measures that could reduce exposure.</p>



<p class="wp-block-paragraph">On 24 July 2026, the Italian Supreme Court of Cassation issued Order No. 24015/2026, setting aside the Bologna Court of Appeal’s earlier judgment and remitting the case to that court for reconsideration by a differently constituted panel.[11]</p>



<p class="wp-block-paragraph">The court held that compliance with technical standards or CE marking did not, by itself, exempt the manufacturer from its duties to provide adequate consumer information and take appropriate precautions. It explained that additional measures, including suitable warnings about risks not immediately apparent to consumers, may be necessary to protect consumer health.[11]</p>



<p class="wp-block-paragraph"><strong>Case status:</strong> At the time of writing, the case had been remitted to the Bologna Court of Appeal for reconsideration. No subsequent final outcome could be confirmed from the publicly available sources reviewed.</p>



<p class="wp-block-paragraph"><strong>Legal scope:</strong> The decision interprets Italian law within a framework that includes EU law. It does not automatically create legal obligations worldwide or determine the outcome of similar claims in other countries. Its reasoning may be relevant to comparable consumer-information disputes, depending on the applicable law and the facts of each case.</p>



<p class="wp-block-paragraph">The ruling did not establish that Apple was liable, that the iPhone caused illness, or that RF exposure causes adverse health effects. It addressed the manufacturer’s legal duties and the need for adequate consumer information and appropriate precautions.</p>



<h3 class="wp-block-heading"><strong>6. Canadian Class-Action Proceedings Against Apple and Samsung</strong></h3>



<p class="wp-block-paragraph"><strong>Canada | Developments in 2022–2025 | Class-action proceedings</strong></p>



<p class="wp-block-paragraph">The Canadian proceedings concern allegations relating to RF exposure, consumer protection and the adequacy of safety information provided to cellphone users.</p>



<p class="wp-block-paragraph">On 22 September 2022, the Quebec Superior Court authorised part of the proposed class action, including claims that inadequate safety instructions could breach Quebec’s Consumer Protection Act and support a claim for punitive damages. In September 2024, the Quebec Court of Appeal dismissed the manufacturers’ appeals, leaving the authorisation in place.[12]</p>



<p class="wp-block-paragraph">In May 2025, the Supreme Court of Canada dismissed Apple’s and Samsung’s applications for leave to appeal the Quebec Court of Appeal’s judgment. The Court dismissed both applications with costs to the respondents.[13][14]</p>



<p class="wp-block-paragraph">The Supreme Court’s refusal to grant leave was not a determination of the scientific merits of the RF-exposure allegations. It did not establish that either manufacturer was liable for harm or had breached consumer-protection requirements.</p>



<p class="wp-block-paragraph">The Quebec class-action registry lists further case-management orders dated February and July 2025. However, the publicly listed documents reviewed for this article do not establish whether discovery has concluded or whether a trial date has been set. The current procedural stage beyond these recorded developments could not be confirmed from the publicly available registry.[12]</p>



<p class="wp-block-paragraph">The proceedings allow the authorised claims to continue, but the allegations have not thereby been proven, and liability and damages have not been determined.</p>



<h2 class="wp-block-heading"><strong>Regulatory Transparency and Access to Documents</strong></h2>



<h3 class="wp-block-heading"><strong>Phonegate Alert and the European Commission: Access to iPhone 12 Documents</strong></h3>



<p class="wp-block-paragraph"><strong>European Union | 2026 | Access-to-documents dispute</strong></p>



<p class="wp-block-paragraph">Phonegate Alert is challenging the European Commission’s decision on access to documents concerning the radiofrequency (RF) exposure compliance assessment of the iPhone 12 A2403.</p>



<p class="wp-block-paragraph">In a confirmatory decision dated 10 August 2026 (C(2026) 5810), the Commission granted full access to some documents, partial access to others and refused access to certain information. The decision concerns documents relating to technical aspects of the iPhone 12 assessment, including testing procedures, technical configurations and the Time Averaged SAR (TAS) procedure.[15,17]</p>



<p class="wp-block-paragraph">Phonegate Alert argues that further disclosure is needed to enable independent scrutiny of the testing and market-surveillance process. The association challenges the withholding of information on commercial-confidentiality grounds and argues that environmental-information law and the public interest in transparency support greater disclosure. These are the association’s legal arguments; they have not yet been determined by the Court.[15,17]</p>



<p class="wp-block-paragraph">On 19 October 2026, Phonegate Alert brought an action for annulment before the General Court of the European Union, challenging the Commission’s decision. Registered as Case T-697/26, <em>Alerte Phonegate v Commission</em>, the case is pending.[16]</p>



<p class="wp-block-paragraph">The dispute concerns access to regulatory documents and the balance between commercial confidentiality and public transparency. It is not a direct personal-injury claim against Apple. The filing does not establish that the Commission acted unlawfully, that testing was deliberately manipulated or that the iPhone 12 caused harm.</p>



<h2 class="wp-block-heading"><strong>Occupational Health: Claims Involving Mobile-Phone Use at Work</strong></h2>



<p class="wp-block-paragraph">Italian courts have considered several individual occupational compensation claims brought by workers who attributed tumours affecting nerves in the head to prolonged use of mobile or cordless phones at work. These proceedings concerned entitlement to compensation from INAIL, Italy’s workers’ compensation authority.</p>



<p class="wp-block-paragraph">The courts assessed the evidence in each individual case, including the reported exposure history and medical expert opinions. The outcomes must be understood in the context of the facts and legal standards applicable to each claim; they do not, by themselves, establish that mobile-phone use generally causes tumours.[18]</p>



<h3 class="wp-block-heading"><strong>Marcolini v. INAIL (Italy, 2012)</strong></h3>



<p class="wp-block-paragraph">In judgment No. 17438 of 12 October 2012, the Italian Court of Cassation rejected INAIL’s appeal, leaving in place an award of occupational disability compensation to a worker who had used mobile and cordless phones at his left ear for approximately five to six hours daily over 12 years.[18]</p>



<p class="wp-block-paragraph">The diagnosed tumour was a <em>neurinoma of the Gasserian ganglion</em>, affecting the trigeminal nerve. This is distinct from an acoustic neuroma, which affects the vestibulocochlear nerve. The Brescia Court of Appeal had awarded an occupational disability pension based on an assessment of 80% disability.</p>



<p class="wp-block-paragraph">The lower court had found the evidence sufficient to support a probable causal link between the worker’s prolonged occupational exposure and his illness under the legal standard for recognising an occupational disease. The Court of Cassation found no legal error warranting reversal of that decision.[18]</p>



<p class="wp-block-paragraph"><strong>Outcome:</strong> The occupational compensation award was upheld. The decision recognised a causal contribution in this individual case under the applicable occupational compensation standard; it did not establish that mobile-phone use generally causes tumours.</p>



<h3 class="wp-block-heading"><strong>Romeo v. INAIL (Ivrea, 2017; Turin Court of Appeal, 2020)</strong></h3>



<p class="wp-block-paragraph">In <em>Romeo v. INAIL</em>, the Ivrea Labour Court, in judgment No. 96/2017, recognised Roberto Romeo’s claim for occupational compensation relating to an acoustic neuroma. The court found that the condition had caused permanent biological impairment assessed at 23% and ordered INAIL to pay the corresponding benefit.[19]</p>



<p class="wp-block-paragraph">INAIL appealed. On 13 January 2020, the Turin Court of Appeal, in judgment No. 904/2020, rejected the appeal and upheld the award. After reviewing additional medical expert evidence, the court concluded that the evidence supported a causal link between Romeo’s prolonged occupational use of mobile phones and his illness, applying the civil-law standard of “more likely than not”. [20]</p>



<p class="wp-block-paragraph"><strong>Outcome:</strong> The occupational compensation award was upheld on appeal in 2020. No subsequent decision by the Italian Court of Cassation could be confirmed from the publicly available sources reviewed.</p>



<h3 class="wp-block-heading">A.M. v. INAIL (Florence, 2017)</h3>



<p class="wp-block-paragraph">In Judgment No. 391/2017, the Florence Labour Court considered a claim by a worker whose employment involved prolonged mobile-phone use. The worker had developed a neurinoma of the eighth cranial nerve, also known as an acoustic neuroma, affecting the right side.</p>



<p class="wp-block-paragraph">The judgment records occupational mobile-phone use from 1994 to 2007, including approximately three hours daily until 1997 and at least two hours daily from 1997 to 2007. After considering medical expert evidence, the court accepted that occupational exposure could have contributed to the development of the illness.[21]</p>



<p class="wp-block-paragraph">The court ordered INAIL to pay an occupational disability benefit based on a permanent impairment assessment of 16%, effective from 12 February 2013.[21]</p>



<p class="wp-block-paragraph">Outcome: The court awarded an occupational disability benefit based on a 16% permanent impairment assessment. No subsequent appeal or Court of Cassation outcome could be confirmed from the publicly available sources reviewed.</p>



<h3 class="wp-block-heading">Aosta Labour Court and Turin Court of Appeal (2020–2022)</h3>



<p class="wp-block-paragraph">This occupational compensation case concerned a worker employed at a steelworks in Aosta who developed a <em>neurinoma of the left acoustic nerve</em>, commonly called an acoustic neuroma. He attributed the illness to extensive mobile-phone use during his employment between 1995 and 2008.</p>



<p class="wp-block-paragraph">In judgment No. 25/2020, published on 4 July 2020, the Aosta Labour Court partially upheld the claim and ordered INAIL to pay the benefit corresponding to a permanent impairment assessment of 53%.[22]</p>



<p class="wp-block-paragraph">INAIL appealed. On 3 November 2022, the Turin Court of Appeal, in judgment No. 519/2022, rejected the appeal and upheld the award. The appellate court obtained a further medical expert assessment to examine the causal relationship between the worker’s occupational exposure and his illness.[22]</p>



<p class="wp-block-paragraph">The judgment records evidence of extensive phone use during working hours and additional use outside working hours while the worker was on call. The expert assessment considered different estimates of cumulative exposure, reflecting assumptions about the exposure period and daily use. The appellate expert assessed overall biological impairment at 57%, but the court could not increase the award because the worker had not appealed the original impairment assessment.</p>



<p class="wp-block-paragraph"><strong>Outcome:</strong> The original compensation award, based on a 53% impairment assessment, remained in place after the appeal. The appellate court accepted a causal link in this individual occupational compensation case; its decision did not establish a general causal relationship between mobile-phone use and acoustic neuromas.</p>



<p class="wp-block-paragraph">No subsequent Court of Cassation outcome could be confirmed from the publicly available sources reviewed.</p>



<h3 class="wp-block-heading">What do the Italian compensation rulings establish?</h3>



<p class="wp-block-paragraph">Italian court decisions awarding compensation for tumours that claimants attributed to prolonged occupational use of mobile phones are relevant to the debate about radiofrequency (RF) exposure and health. In several cases, courts accepted evidence of a causal or contributory relationship between the claimant’s exposure and the diagnosed condition under the applicable Italian legal test. These findings should not be dismissed or misrepresented.[18–22]</p>



<p class="wp-block-paragraph">However, a finding in an individual case is not equivalent to establishing a general causal relationship across the population. The courts assessed the evidence presented in particular proceedings, including expert medical opinions, the claimant’s exposure history and the applicable legal standard. The outcomes do not, by themselves, establish the magnitude of any risk to ordinary mobile-phone users or resolve the wider scientific debate.</p>



<p class="wp-block-paragraph">The distinction works both ways: a court ruling does not, on its own, establish a general scientific conclusion, but neither does uncertainty in the wider scientific evidence invalidate a court’s findings in an individual case. The Italian decisions therefore form part of the legal record and warrant consideration alongside epidemiological research, scientific reviews and assessments by public-health authorities.</p>



<h2 class="wp-block-heading"><strong>Overall Assessment</strong></h2>



<p class="wp-block-paragraph">Mobile Phone Radiation Litigation encompasses several distinct types of legal proceedings. Some cases have been dismissed because of federal pre-emption or because plaintiffs did not present expert evidence that met the applicable admissibility standards. Others have concerned consumer-information duties, the procedural requirements for class actions, individual occupational compensation or access to regulatory documents.</p>



<p class="wp-block-paragraph">The outcomes must be understood within their respective legal contexts. A decision allowing a claim to proceed is not proof that the allegations are true. A refusal of leave to appeal does not necessarily determine the scientific merits. An occupational compensation award concerns the evidence and legal criteria applied to an individual claimant, while an access-to-documents dispute concerns transparency and the law governing disclosure.</p>



<p class="wp-block-paragraph">Taken together, these cases illustrate how courts address questions of evidence, regulatory authority, consumer information and access to documents. They do not amount to a single, uniform judicial conclusion about the health effects of mobile-phone radiofrequency (RF) exposure.</p>



<h1 class="wp-block-heading">References</h1>



<h2 class="wp-block-heading">Claims Against Manufacturers</h2>



<p class="wp-block-paragraph"><strong>[</strong>1<strong>]</strong> U.S. Court of Appeals for the Fourth Circuit. Pinney v. Nokia, Inc., 402 F.3d 430 (4th Cir. 2005). <a href="https://law.justia.com/cases/federal/appellate-courts/F3/402/430/510044/">Judgement</a><br></p>



<p class="wp-block-paragraph"><strong>[</strong>2<strong>]</strong> <a href="https://www.sec.gov/Archives/edgar/data/68505/000095013707003011/c11830e10vk.htm">Motorola, Inc. <em>Form 10-K</em></a><em> for the fiscal year ended 31 December 2006</em>, “Item 3: Legal Proceedings,” pp. 25–26. U.S. Securities and Exchange Commission. </p>



<p class="wp-block-paragraph"><strong>[</strong>3<strong>]</strong> <a href="https://media.corporate-ir.net/media_files/IROL/90/90829/reports/MOT200510Ka.pdf">Motorola, Inc. <em>2005 Annual Report</em></a>, litigation discussion concerning wireless telephone usage.<br></p>



<p class="wp-block-paragraph"><strong>[</strong>4<strong>]</strong> <a href="https://caselaw.findlaw.com/court/us-3rd-circuit/1542287.html">U.S. Court of Appeals for the Third Circuit. <em>Farina v. Nokia, Inc</em></a><em>.</em>, 625 F.3d 97 (3d Cir. 2010), decided 22 October 2010.<br></p>



<p class="wp-block-paragraph">[5] Supreme Court of the United States. <em>Farina v. Nokia</em>, Case No. 10-1064. <a href="https://www.supremecourt.gov/Search.aspx?FileName=%2Fdocketfiles%2F10-1064.htm">View Supreme Court docket</a><br></p>



<p class="wp-block-paragraph">[6] <a href="https://cdn.ca9.uscourts.gov/datastore/opinions/2022/08/26/20-17307.pdf">U.S. Court of Appeals for the Ninth Circuit. Cohen v. Apple Inc., No. 20-17307, 26 August 2022</a>.<br></p>



<p class="wp-block-paragraph">[7] <a href="https://law.justia.com/cases/district-of-columbia/court-of-appeals/2009/07-cv-1074-5.html">District of Columbia Court of Appeals. <em>Murray v. Motorola, Inc.</em>, 982 A.2d 764 (2009), amended 10 December 2009</a>.<br></p>



<p class="wp-block-paragraph">[8] <a href="https://law.justia.com/cases/district-of-columbia/court-of-appeals/2016/14-cv-1350.html">District of Columbia Court of Appeals, sitting en banc. <em>Motorola, Inc. v. Murray</em>, 147 A.3d 751 (2016)</a>.<br></p>



<p class="wp-block-paragraph"><strong>[</strong>9<strong>]</strong> <a href="https://law.justia.com/cases/district-of-columbia/court-of-appeals/2025/23-cv-0700.html">District of Columbia Court of Appeals. <em>Murray v. Motorola, Inc.</em>, No. 23-CV-0700, 17 July 2025.<br></a></p>



<p class="wp-block-paragraph">[10<strong>]</strong><a href="https://law.justia.com/cases/district-of-columbia/court-of-appeals/2026/24-cv-0739.html"> District of Columbia Court of Appeals. Brooks v. Mitsubishi Electric &amp; Electronics USA, Inc., No. 24-CV-0739, 16 July 2026.</a></p>



<p class="wp-block-paragraph">[11] Italian Court of Cassation. <em>Order No. 24015/2026</em>, 24 July 2026 (<em>Briganti v. Apple Distribution International Ltd.</em>). <a href="https://www.ambientediritto.it/giurisprudenza/corte-di-cassazione-civile-sez-3-24-luglio-2026-ordinanza-n-24015/">Read the order.</a><br></p>



<p class="wp-block-paragraph">[12] <a href="https://www.registredesactionscollectives.quebec/en/Consulter/ApercuDemande?NoDossier=500-06-001018-197">Quebec Class Action Registry. File No. 500-06-001018-197</a>.<br></p>



<p class="wp-block-paragraph">[13] <a href="https://www.scc-csc.ca/cases-dossiers/search-recherche/41555/">Supreme Court of Canada. <em>Apple</em>, Case No. 41555.</a><br></p>



<p class="wp-block-paragraph">[14] <a href="https://scc-csc.gc.ca/cases-dossiers/search-recherche/41548/">Supreme Court of Canada. <em>Samsung</em>, Case No. 41548.<br></a></p>



<h2 class="wp-block-heading">Regulatory Transparency and Access to Documents</h2>



<p class="wp-block-paragraph">[15] <a href="https://ec.europa.eu/transparency/documents-request/api/portal/externalizedDocument/ers/080166e3866f218d/false/download">European Commission. Decision C(2026) 5810, 10 August 2026</a>.<br>European Commission. <em>Commission Implementing Decision (EU) 2025/1760</em>, 19 August 2025, concerning the French                  measure relating to the Apple iPhone 12 A2403. <a href="https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32025D1760">Read the Implementing Decision</a>.</p>



<p class="wp-block-paragraph">[16] <a href="https://infocuria.curia.europa.eu/tabs/affair?lang=EN&amp;publishedId=T-697%2F26">General Court of the European Union. <em>Alerte Phonegate v Commission</em>, Case T-697/26.</a><br></p>



<p class="wp-block-paragraph">[17] <a href="https://phonegatealert.org/recours-iphone-12-commission-europeenne/">Phonegate Alert. Alerte Phonegate v Commission européenne: Recours concernant l’accès aux documents techniques de l’iPhone 12. 20 October 2026.</a><br></p>



<h2 class="wp-block-heading">Occupational Health</h2>



<p class="wp-block-paragraph">[18] <a href="https://olympus.uniurb.it/index.php?Itemid=138&amp;catid=16&amp;id=7915%3Acassazione-civile-12-ottobre-2012-n-17438-uso-di-telefoni-nel-corso-dellattivita-lavorativa-e-patologia-tumorale&amp;option=com_content&amp;view=article">Italian Court of Cassation. Judgment No. 17438, 12 October 2012 (<em>Marcolini v. INAIL</em>).</a><br></p>



<p class="wp-block-paragraph">[19] <a href="https://www.certifico.com/news/malattie-professionali-prima-sentenza-sul-nesso-uso-cellulare-e-neurinoma">Ivrea Labour Court. Judgment No. 96/2017, 30 March 2017.</a><br></p>



<p class="wp-block-paragraph">[20] <a href="https://olympus.uniurb.it/index.php?Itemid=148&amp;id=21679%3Acorte-di-appello-di-torino%2C-sez-lav-%2C-13-gennaio-2020%2C-n-904-uso-prolungato-del-cellulare-e-tumore-alla-testa-nesso-causale-secondo-criteri-probabilistici-del-pi%C3%B9-probabile-c&amp;option=com_content&amp;view=article">Turin Court of Appeal. Judgment No. 904/2020, 13 January 2020.</a><br></p>



<p class="wp-block-paragraph">[21] <a href="https://olympus.uniurb.it/index.php?id=17502%3Atribunale-di-firenze%2C-24-giugno-2017%2C-n-391-il-nesso-causale-tra-la-patologia-e-l%E2%80%99utilizzo-del-cellulare-per-attivit%C3%A0-lavorativa-non-%C3%A8-escluso-dalla-circostanza-d&amp;option=com_content&amp;view=article">Florence Labour Court, Judgment No. 391/2017 (</a><em><a href="https://olympus.uniurb.it/index.php?id=17502%3Atribunale-di-firenze%2C-24-giugno-2017%2C-n-391-il-nesso-causale-tra-la-patologia-e-l%E2%80%99utilizzo-del-cellulare-per-attivit%C3%A0-lavorativa-non-%C3%A8-escluso-dalla-circostanza-d&amp;option=com_content&amp;view=article">A.M. v. INAIL</a></em><a href="https://olympus.uniurb.it/index.php?id=17502%3Atribunale-di-firenze%2C-24-giugno-2017%2C-n-391-il-nesso-causale-tra-la-patologia-e-l%E2%80%99utilizzo-del-cellulare-per-attivit%C3%A0-lavorativa-non-%C3%A8-escluso-dalla-circostanza-d&amp;option=com_content&amp;view=article">)</a><br></p>



<p class="wp-block-paragraph">[22] Turin Court of Appeal. <em>Judgment No. 519/2022, 3 November 2022</em> (referring to Aosta Labour Court Judgment No. 25/2020, published 4 July 2020). <a href="https://olympus.uniurb.it/index.php?Itemid=138&amp;catid=72&amp;id=29736%3Acorte-d-appello-di-torino%2C-sez-lav-%2C-03-novembre-2022%2C-n-519-uso-massivo-del-telefono-cellulare&amp;option=com_content&amp;view=article">Read the judgment</a>.<br></p>



<h2 class="wp-block-heading">Legal Disclaimer</h2>



<p class="wp-block-paragraph">This article is provided for general information and educational purposes only. It is not legal advice and should not be relied upon as a substitute for advice from a qualified legal professional.</p>



<p class="wp-block-paragraph">The cases and proceedings discussed are selected examples and may not represent all relevant litigation. The information reflects the sources reviewed at the time of publication. Case status, appeals and legal interpretations may change. Readers should consult original judgments, official court records and relevant legislation when assessing a particular case.</p>



<p class="wp-block-paragraph">Descriptions of allegations do not imply that they have been proven. Decisions concerning jurisdiction, procedural requirements, admissibility of evidence, consumer information, occupational compensation or access to documents must be understood in their specific legal context. An outcome in an individual case does not necessarily establish a general scientific conclusion or determine the outcome of other cases.</p>



<p class="wp-block-paragraph">EMFSA makes no representation that the information is exhaustive or that every subsequent development has been independently confirmed. Nothing in this article should be interpreted as a determination of legal liability, a medical assessment or a conclusion that mobile-phone radiofrequency (RF) exposure does or does not cause a particular health condition.</p>



<p class="wp-block-paragraph">Readers seeking advice about their own circumstances should consult an appropriately qualified legal or medical professional, as applicable.</p>



<h2 class="wp-block-heading">Further Reading</h2>



<p class="wp-block-paragraph"><a href="https://www.emfsa.co.za/safety/metal-components-in-body-worn-accessories/">Metal Components in Body-Worn Accessories: Smartphone Compliance Guidance</a></p>



<p class="wp-block-paragraph">EMFSA  | 28 October 2026</p>



<p class="wp-block-paragraph"></p>
<p>The post <a href="https://www.emfsa.co.za/news/legal/mobile-phone-radiation-litigation/">Mobile Phone Radiation Litigation</a> appeared first on <a href="https://www.emfsa.co.za">EMFSA</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>EU Decision 2026/2003: RF-EMF Exposure</title>
		<link>https://www.emfsa.co.za/safety/eu-decision-2026-2003-rf-emf-exposure/</link>
		
		<dc:creator><![CDATA[Editor]]></dc:creator>
		<pubDate>Sat, 17 Oct 2026 15:11:37 +0000</pubDate>
				<category><![CDATA[Safety]]></category>
		<category><![CDATA[RF Exposure Standards]]></category>
		<category><![CDATA[RF-EMF Exposure]]></category>
		<category><![CDATA[SAR Testing]]></category>
		<guid isPermaLink="false">https://www.emfsa.co.za/?p=32854</guid>

					<description><![CDATA[<p>What Does EU Decision 2026/2003 Mean for RF-EMF Exposure? The European Commission adopted Implementing Decision (EU) 2026/2003 on 4 September 2026. It was published in the Official Journal of the European Union on 7 September 2026. The decision updates the EU’s list of harmonised standards for radio equipment. Commission Implementing Decision (EU) 2026/2003 One relevant [&#8230;]</p>
<p>The post <a href="https://www.emfsa.co.za/safety/eu-decision-2026-2003-rf-emf-exposure/">EU Decision 2026/2003: RF-EMF Exposure</a> appeared first on <a href="https://www.emfsa.co.za">EMFSA</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<h1 class="wp-block-heading"><strong>What Does EU Decision 2026/2003 Mean for RF-EMF Exposure?</strong></h1>



<p class="wp-block-paragraph">The European Commission adopted Implementing Decision (EU) 2026/2003 on 4 September 2026. It was published in the <em>Official Journal of the European Union</em> on 7 September 2026. The decision updates the EU’s list of harmonised standards for radio equipment. <a href="https://eur-lex.europa.eu/eli/dec_impl/2026/2003/oj">Commission Implementing Decision (EU) 2026/2003</a></p>



<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="515" height="281" src="https://www.emfsa.co.za/wp-content/uploads/2026/10/RF-Exposure-Compliance.jpg" alt="Graphic titled “RF-Exposure Compliance” explaining what a test result establishes and what it does not." class="wp-image-32900" srcset="https://www.emfsa.co.za/wp-content/uploads/2026/10/RF-Exposure-Compliance.jpg 515w, https://www.emfsa.co.za/wp-content/uploads/2026/10/RF-Exposure-Compliance-300x164.jpg 300w" sizes="auto, (max-width: 515px) 100vw, 515px" /></figure>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph">One relevant change concerns the harmonised reference for EN 50566, a standard for assessing compliance of wireless communication devices with basic restrictions and exposure limit values related to human exposure to electromagnetic fields. The decision provides for EN 50566:2017, together with amendments A1:2023 and A2:2025, to be included in the updated harmonised standards list from 7 March 2028.</p>



<h3 class="wp-block-heading">What Does the Amended EN 50566 Standard Cover?</h3>



<p class="wp-block-paragraph">The decision updates harmonised standards for several categories of radio equipment. These include location-tracking equipment, cellular communication base stations, ultra-wideband devices, fixed radio systems and other radio technologies.</p>



<p class="wp-block-paragraph">EN 50566 has a more specific scope. It covers handheld and body-mounted wireless communication devices used close to the human body and operating between 30 MHz and 6 GHz. It provides a product standard for demonstrating compliance with applicable basic restrictions and exposure limit values.</p>



<p class="wp-block-paragraph">The 2025 amendment, <a href="https://www.nen.nl/en/nen-en-50566-2017-a2-2025-en-344126">EN 50566:2017/A2:2025</a>, forms part of the updated harmonised reference for assessing human exposure to electromagnetic fields from wireless communication devices used close to the body.</p>



<p class="wp-block-paragraph"><strong>Source access:</strong> NEN lists the English-language amendment as published on 1 November 2025 and available for purchase. The full text is not freely available on the catalogue page. Readers should consult the amendment itself for its specific technical provisions.</p>



<h2 class="wp-block-heading">What Are Harmonised Standards?</h2>



<p class="wp-block-paragraph">Harmonised standards provide technical procedures that manufacturers can use to demonstrate that their products meet applicable EU legal requirements. References to these standards are published in the <em>Official Journal of the European Union</em>.</p>



<p class="wp-block-paragraph">Under the Radio Equipment Directive, compliance with a harmonised standard whose reference has been published in the <em>Official Journal</em> confers a presumption of conformity with the essential requirements covered by that standard.</p>



<p class="wp-block-paragraph">For RF-exposure assessment, EN 50566 specifies procedures for assessing compliance with applicable exposure requirements.</p>



<h2 class="wp-block-heading">What Is the Transition Period?</h2>



<p class="wp-block-paragraph">The decision provides a transition period for the earlier EN 50566 references. The updated harmonised reference, which includes amendments A1:2023 and A2:2025, applies from 7 March 2028. On that date, the references to EN 50566:2017 and amendment A1:2023 are scheduled to be withdrawn from the <em>Official Journal of the European Union</em>. This gives manufacturers time to adapt to the updated standard.</p>



<h3 class="wp-block-heading">What Does This Mean for Consumers?</h3>



<p class="wp-block-paragraph">Compliance assessments apply to specified device configurations and test conditions. An important question is how well those conditions represent the different ways people carry and use wireless devices in everyday life, particularly when body-worn accessories are involved.</p>



<p class="wp-block-paragraph">The following international documents provide further technical context. They describe approaches to exposure assessment and SAR measurement, but neither automatically replaces or amends EN 50566. Their publication does not, by itself, establish a new universal RF-exposure limit.</p>



<h3 class="wp-block-heading">Two International Documents Provide Further Context</h3>



<h4 class="wp-block-heading">ITU-T Recommendation K.160 — Exposure Assessment Guidance</h4>



<p class="wp-block-paragraph"><strong>Approved: 14 December 2025</strong></p>



<p class="wp-block-paragraph">ITU-T Recommendation K.160 provides guidance on assessing human exposure to radiofrequency electromagnetic fields from wireless communication devices used close to the body.</p>



<p class="wp-block-paragraph">It covers several assessment methods, including specific absorption rate (SAR), absorbed power density (APD) and incident power density (IPD). It also addresses device operating conditions, proximity sensors, time-averaged SAR and exposure from multiple transmitters or operating modes.</p>



<p class="wp-block-paragraph">K.160 refers to existing international standards for measurement and assessment. The applicable exposure limits depend on the relevant regulatory framework or guidelines.</p>



<p class="wp-block-paragraph"><a href="https://www.itu.int/rec/T-REC-K.160/en">Read the official ITU-T K.160 Recommendation</a></p>



<h4 class="wp-block-heading">IEC/IEEE 62209-1528 — SAR Measurement Procedures</h4>



<p class="wp-block-paragraph"><strong>Amendment 1 published: 2 September 2026</strong></p>



<p class="wp-block-paragraph">IEC/IEEE 62209-1528 specifies procedures for measuring SAR from handheld and body-mounted wireless communication devices used near the head and body. It covers frequencies from 4 MHz to 10 GHz.</p>



<p class="wp-block-paragraph">Amendment 1:2026 addresses hand SAR, motion sensors, time-averaged SAR algorithm validation, proximity sensors, separation distances and procedures for reducing certain SAR tests.</p>



<p class="wp-block-paragraph"><strong>Sources:</strong></p>



<ul class="wp-block-list">
<li><a href="https://standards.ieee.org/ieee/62209-1528a/11607/"><strong>IEEE: Amendment 1 details</strong></a></li>



<li><a href="https://webstore.iec.ch/en/publication/90054"><strong>IEC: Amendment 1 publication record</strong></a></li>



<li><a href="https://webstore.iec.ch/en/publication/116521"><strong>IEC: Consolidated standard details</strong></a></li>
</ul>



<h3 class="wp-block-heading">What Does Amendment 1 to IEC/IEEE 62209-1528 Change?</h3>



<p class="wp-block-paragraph">Amendment 1 adds or revises procedures for assessing SAR from wireless communication devices. The main areas addressed are outlined below.</p>



<h6 class="wp-block-heading"><strong>Hand SAR</strong></h6>



<p class="wp-block-paragraph">The amendment introduces an applicability check and a measurement procedure for hand SAR in specified circumstances. This is relevant to the assessment of devices used in the hand. It does not mean that every existing phone model will automatically be retested or that hand exposure has suddenly increased.</p>



<h6 class="wp-block-heading"><strong>Motion and proximity sensors</strong></h6>



<p class="wp-block-paragraph">The amendment adds procedures for measuring SAR in devices with motion sensors, including a sensor-validation annex. It also addresses proximity-sensor assessment.</p>



<p class="wp-block-paragraph">These sensors can affect how a device operates when its position, movement or proximity to the user changes. The amendment specifies procedures for assessing relevant sensor behaviour during compliance testing.</p>



<h6 class="wp-block-heading"><strong>Time-averaged SAR</strong></h6>



<p class="wp-block-paragraph">The amendment revises procedures for validating algorithms used to assess time-averaged SAR. Some devices use power-control mechanisms that manage transmission over time. The updated procedures address how these algorithms are validated during compliance assessment.</p>



<p class="wp-block-paragraph">They do not establish that every device using power control will produce lower exposure in every circumstance.</p>



<h6 class="wp-block-heading"><strong>Separation distances and test reduction</strong></h6>



<p class="wp-block-paragraph">Separation distance affects the configuration used during testing. Amendment 1 also introduces a conditional procedure that can reduce the need for certain head-SAR tests.</p>



<p class="wp-block-paragraph">For devices used next to the ear, a test using a SAM (Specific Anthropomorphic Mannequin) head phantom may not be required for a particular antenna and frequency combination if specified conditions are met. These include:</p>



<ul class="wp-block-list">
<li>Testing the device&#8217;s front side in direct contact with a flat phantom at a separation distance of 0 mm, using the same operating conditions that apply to use next to the ear.</li>



<li>Confirming that the device&#8217;s front side is planar.</li>



<li>Demonstrating that the time-averaged output power next to the ear is no higher than the power used in the flat-phantom measurement.</li>



<li>Documenting the justification in the test report.</li>
</ul>



<h6 class="wp-block-heading">The flat-phantom result must also meet at least one of two criteria:</h6>



<ol start="1" class="wp-block-list">
<li>The peak spatial-average SAR (psSAR) must be at least 5 dB below the applicable head-SAR limit; or</li>



<li>The centre of the psSAR cube must be at least 95.4 mm from the device&#8217;s acoustic output along the specified vertical centreline, and the spatial-average SAR at all locations within 95.4 mm of the acoustic output must be at least 5 dB below the applicable head-SAR limit.</li>
</ol>



<p class="wp-block-paragraph">This is a conditional test-reduction procedure, not a general exemption from head-SAR testing. The amendment cautions that some regulatory authorities may not accept flat-phantom SAR measurements as a substitute for SAM-phantom measurements. National regulatory requirements must therefore be considered.</p>



<p class="wp-block-paragraph"><strong>Sources:</strong></p>



<p class="wp-block-paragraph"><a href="https://webstore.iec.ch/en/publication/116521"><strong>Official IEC publication record</strong></a></p>



<p class="wp-block-paragraph"><a href="https://standards.ieee.org/ieee/62209-1528a/11607/"><strong>Official IEEE amendment record</strong></a></p>



<h3 class="wp-block-heading">What Do These Changes Mean for RF-Exposure Assessment?</h3>



<p class="wp-block-paragraph">Changes to measurement procedures can affect compliance results because the test arrangement, assumptions or procedures may differ. A change in a reported result does not, by itself, establish that a person&#8217;s actual RF exposure in everyday use has increased or decreased.</p>



<p class="wp-block-paragraph">Similarly, a lower measured SAR value does not automatically establish lower exposure across every operating mode or device configuration. SAR is one measure used in RF-exposure assessment. APD and IPD are also relevant to particular assessment methods and frequency ranges.</p>



<p class="wp-block-paragraph">Publication of Amendment 1 does not, by itself, establish that earlier phones were inadequately tested, that newer phones will have higher or lower SAR values, or that regulators in every country will immediately adopt the revised procedures.</p>



<p class="wp-block-paragraph">These questions require separate evidence and consideration of the applicable regulatory framework.</p>



<h3 class="wp-block-heading">How Confidently Can a Compliance Result Be Applied to Everyday Use?</h3>



<p class="wp-block-paragraph">A compliance result applies to the device and conditions assessed under the relevant procedure. Applying it to a different configuration depends on whether the differences are covered by the test method or otherwise accounted for in the assessment.</p>



<p class="wp-block-paragraph">Factors such as the device&#8217;s position relative to the body, separation distance, operating mode and accessories may affect the assessment. A phone tested in one configuration should not automatically be assumed to have the same exposure characteristics when used with a different case or body-worn accessory. The significance of any difference depends on the device and the conditions assessed.</p>



<p class="wp-block-paragraph">This does not mean that every change in configuration invalidates a compliance result. The scope of the assessment and the manufacturer&#8217;s instructions are important when interpreting the result.</p>



<h3 class="wp-block-heading">What Does SAR Testing Establish—and What Does It Not?</h3>



<p class="wp-block-paragraph">Specific absorption rate (SAR) measures the rate at which radiofrequency energy is absorbed per unit mass of tissue. It is expressed in watts per kilogram (W/kg). Standardised SAR testing assesses compliance with applicable SAR limits under specified test conditions.</p>



<p class="wp-block-paragraph">SAR is a physical measurement quantity, not a direct test for biological effects. SAR testing does not directly measure biological endpoints such as changes in cellular signalling, oxidative stress or gene expression. Researchers have investigated these endpoints in studies of possible non-thermal effects.</p>



<p class="wp-block-paragraph">A compliant SAR result does not, by itself, establish the absence of every possible biological effect.</p>



<p class="wp-block-paragraph">RF-exposure guidelines aim to protect against established adverse effects. For RF fields, current guidelines are principally based on established effects associated with excessive tissue heating. Questions about other possible effects, and whether the evidence supports additional protective measures, are separate from whether a device meets the applicable exposure limits.</p>



<p class="wp-block-paragraph"><a href="https://www.icnirp.org/en/publications/article/rf-guidelines-2020.html">Read the ICNIRP RF-EMF Guidelines (2020)</a></p>



<p class="wp-block-paragraph">ITU-T Recommendation K.160 does not introduce a test for non-thermal biological effects. It provides guidance on assessing exposure against applicable limits using existing measurement standards. Depending on the frequency range and assessment method, the relevant physical quantities include SAR, absorbed power density (APD) and incident power density (IPD).</p>



<p class="wp-block-paragraph">A measurement standard specifies how exposure is assessed. It does not, by itself, resolve every scientific question about possible health effects.</p>



<h3 class="wp-block-heading">The iPhone 12 A2403 Example: Contact Measurements and Software</h3>



<p class="wp-block-paragraph">The European Commission’s 2025 decision on the iPhone 12 A2403 illustrates how test procedures and software behaviour can affect RF-exposure compliance.</p>



<p class="wp-block-paragraph">France’s market surveillance authority, ANFR, found that the iPhone 12 A2403 exceeded the applicable limb SAR limit. Apple disputed the original measurements and proposed an alternative test procedure.</p>



<h4 class="wp-block-heading">Disagreement Over the Test Procedure</h4>



<p class="wp-block-paragraph">Apple’s first proposal, known as Protocol 1, used a separation distance of 1 mm. It also used an external motorised system to trigger the phone’s <em>Body Detect</em> function.</p>



<p class="wp-block-paragraph">ANFR rejected this procedure for three reasons. First, it considered that the maximum SAR was more likely to occur at a separation distance of 0 mm. Second, it considered the artificial triggering mechanism potentially unrepresentative of normal use. Third, the test configuration used to isolate a particular antenna could have an undetermined effect on the measurements.</p>



<p class="wp-block-paragraph">Apple then proposed Protocol 2, which used a separation distance of 0 mm. It also required the volume button to be pressed every 20 seconds to trigger <em>Body Detect</em>. ANFR accepted the revised procedure.</p>



<p class="wp-block-paragraph">However, measurements conducted in August 2023 still found that the phone exceeded the applicable limb SAR limit. The measured value was 5.740 W/kg, against a limit of 4 W/kg.</p>



<h4 class="wp-block-heading">Software Correction and EU-Wide Requirements</h4>



<p class="wp-block-paragraph">Following the release of iOS 17.1, further measurements in September 2023 showed that the phone met the limb SAR limit under the reported test conditions. The tests used equipment simulating a mobile network in France. The software update permanently activated the <em>on-body</em> state of <em>Body Detect</em>, reducing the device’s transmission power and SAR.</p>



<p class="wp-block-paragraph">The Commission also examined whether the corrective software operated throughout the EU. Apple confirmed that the relevant software behaviour applied only to iPhone 12 A2403 devices using cellular networks in France.</p>



<h6 class="wp-block-heading">Article 40(3) of the Radio Equipment Directive requires corrective action for non-compliant radio equipment throughout the EU.</h6>



<p class="wp-block-paragraph">The Commission therefore considered the measure insufficient because the corrective software did not operate throughout the Union.</p>



<p class="wp-block-paragraph">In its decision of 19 August 2025, the Commission concluded that France’s measure to withdraw the iPhone 12 A2403 from the market was justified. This finding concerned the specific A2403 model. It should not be interpreted as a finding that every iPhone 12 model was non-compliant.</p>



<p class="wp-block-paragraph"><a href="https://eur-lex.europa.eu/eli/dec_impl/2025/1760/oj">Read Commission Implementing Decision (EU) 2025/1760</a></p>



<p class="wp-block-paragraph">The case illustrates why test procedures, separation distances, software behaviour and corrective action matter when interpreting compliance results.</p>



<p class="wp-block-paragraph">It also provides context for the later EU standards update. Contact-distance testing is not entirely new. In its 2025 decision, the Commission noted that EN 50566:2017 allowed test distances between 0 and 5 mm and that the worst-case scenario should be considered. It also referred to guidance that typically uses a separation distance of 0 mm, or contact, for head SAR, limb SAR and SAR measurements involving known accessories.</p>



<p class="wp-block-paragraph">The precise technical changes introduced by Amendment A2:2025 should be checked against the amendment itself. The publicly available catalogue description alone is insufficient to establish the full scope of those changes. Until the complete text has been reviewed, the specific requirements for separation distances should not be presented as confirmed. Nor should any change be interpreted as a blanket requirement to test every phone in direct contact with the head.</p>



<h3 class="wp-block-heading">Sources</h3>



<ol start="1" class="wp-block-list">
<li><strong>European Commission.</strong> <em>Commission Implementing Decision (EU) 2025/1760 of 19 August 2025 concerning the measure taken by France with respect to Apple iPhone 12 A2403.</em> Official Journal of the European Union, 1 September 2025. <a href="https://eur-lex.europa.eu/eli/dec_impl/2025/1760/oj">https://eur-lex.europa.eu/eli/dec_impl/2025/1760/oj</a> Relevant sections: paragraphs 18–32 cover the original limb SAR finding, Apple’s proposed test protocols, the 5.740 W/kg result, the iOS 17.1 update and the requirement for corrective action throughout the EU.</li>



<li><strong>European Commission.</strong> <em>Commission Implementing Decision (EU) 2026/2003 of 4 September 2026 amending Implementing Decision (EU) 2022/2191 as regards harmonised standards for radio equipment.</em> <a href="https://eur-lex.europa.eu/eli/dec_impl/2026/2003/oj">https://eur-lex.europa.eu/eli/dec_impl/2026/2003/oj</a> Relevant sections: recitals 6–7 and 11–13, and the Annex, address EN 50566:2017 and amendments A1:2023 and A2:2025, including the transition arrangements.</li>



<li><strong>Nederlands Normalisatie-instituut (NEN).</strong> <em>NEN-EN 50566:2017/A2:2025 en.</em> English-language amendment, published 1 November 2025. <a href="https://www.nen.nl/en/nen-en-50566-2017-a2-2025-en-344126">https://www.nen.nl/en/nen-en-50566-2017-a2-2025-en-344126</a> The catalogue identifies the amendment and its publication details. The full text is available for purchase; the catalogue description alone does not establish the precise technical changes introduced by the amendment.</li>
</ol>



<h3 class="wp-block-heading">Compliance, Everyday Exposure and Health Questions</h3>



<p class="wp-block-paragraph">International standards provide an important technical framework for assessing RF-exposure compliance. However, the interpretation of a compliance result depends on the measurement procedure, the device configuration and the conditions assessed.</p>



<p class="wp-block-paragraph">The updated standards and the iPhone 12 A2403 case illustrate why these details matter. A compliance result establishes whether a device meets the applicable requirements under the specified assessment procedure. It does not, by itself, establish the exposure a user will experience in every everyday-use scenario or resolve all scientific questions about possible long-term health effects.</p>



<p class="wp-block-paragraph">Consumers should consult the manufacturer&#8217;s guidance for their specific device, follow any stated separation distances and use accessories in accordance with the manufacturer&#8217;s instructions. For researchers and regulators, the continuing challenge is to ensure that assessment procedures remain technically robust and relevant to how wireless devices are used in practice.</p>



<p class="wp-block-paragraph"><strong>Disclaimer:</strong> This article summarises published regulatory documents, technical standards and related research for general information. It is not legal or medical advice, nor a product-specific RF-exposure assessment. Readers should consult the relevant primary sources and the manufacturer&#8217;s guidance for their specific device.</p>



<p class="wp-block-paragraph">Further reading <a href="https://www.emfsa.co.za/news/legal-accountability-of-a-guideline-versus-a-standard/">Legal Accountability of a Guideline versus a Standard</a></p>



<p class="wp-block-paragraph">EMFSA | 17 October 2026</p>
<p>The post <a href="https://www.emfsa.co.za/safety/eu-decision-2026-2003-rf-emf-exposure/">EU Decision 2026/2003: RF-EMF Exposure</a> appeared first on <a href="https://www.emfsa.co.za">EMFSA</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Metal Components in Body-Worn Accessories: Smartphone Compliance Guidance</title>
		<link>https://www.emfsa.co.za/safety/metal-components-in-body-worn-accessories/</link>
		
		<dc:creator><![CDATA[Editor]]></dc:creator>
		<pubDate>Tue, 13 Oct 2026 13:43:27 +0000</pubDate>
				<category><![CDATA[Safety]]></category>
		<category><![CDATA[Compliance]]></category>
		<category><![CDATA[Metal]]></category>
		<category><![CDATA[RF]]></category>
		<category><![CDATA[Smartphone]]></category>
		<guid isPermaLink="false">https://www.emfsa.co.za/?p=32652</guid>

					<description><![CDATA[<p>Metal Components in Body-Worn Accessories: Smartphone Compliance Guidance Could the metal components in your phone case or belt clip matter for RF-exposure compliance? Many users know the recommended distance between a smartphone and the body. But what about metal in phone cases and other accessories? Why Do Some Smartphone Manufacturers Issue This Warning? Some smartphone [&#8230;]</p>
<p>The post <a href="https://www.emfsa.co.za/safety/metal-components-in-body-worn-accessories/">Metal Components in Body-Worn Accessories: Smartphone Compliance Guidance</a> appeared first on <a href="https://www.emfsa.co.za">EMFSA</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph"><strong>Metal Components in Body-Worn Accessories: Smartphone Compliance Guidance</strong></p>



<p class="wp-block-paragraph">Could the metal components in your phone case or belt clip matter for RF-exposure compliance? Many users know the recommended distance between a smartphone and the body. But what about metal in phone cases and other accessories?</p>



<h1 class="wp-block-heading"><strong>Why Do Some Smartphone Manufacturers Issue This Warning?</strong></h1>



<p class="wp-block-paragraph">Some smartphone manufacturers specify restrictions on metallic components in accessories used to carry their devices close to the body. Their guidance may also state minimum separation distances and permitted accessory configurations. These instructions vary by device model and jurisdiction.</p>



<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="960" height="540" src="https://www.emfsa.co.za/wp-content/uploads/2026/10/Metal-Components-in-Body-Worn-Accessories.jpg" alt="Title graphic reading Metal Components in Body-Worn Accessories" class="wp-image-32651" style="width:535px;height:auto" srcset="https://www.emfsa.co.za/wp-content/uploads/2026/10/Metal-Components-in-Body-Worn-Accessories.jpg 960w, https://www.emfsa.co.za/wp-content/uploads/2026/10/Metal-Components-in-Body-Worn-Accessories-300x169.jpg 300w, https://www.emfsa.co.za/wp-content/uploads/2026/10/Metal-Components-in-Body-Worn-Accessories-768x432.jpg 768w" sizes="auto, (max-width: 960px) 100vw, 960px" /></figure>



<p class="wp-block-paragraph"></p>



<h3 class="wp-block-heading">Why Can Metallic Components in Body-Worn Accessories Matter?</h3>



<p class="wp-block-paragraph">Metallic components in body-worn accessories can interact with a smartphone&#8217;s antenna and the electromagnetic field around the device. The effects depend on the accessory&#8217;s properties, its position relative to the phone and body, and the phone&#8217;s operating conditions.</p>



<h3 class="wp-block-heading">Metal Can Change Local SAR</h3>



<p class="wp-block-paragraph">Specific Absorption Rate (SAR) measures the rate at which radiofrequency energy is absorbed per unit mass of tissue. It is expressed in watts per kilogram (W/kg). Researchers use numerical models and measurements with tissue-equivalent phantoms to assess SAR under specified test conditions.</p>



<p class="wp-block-paragraph">The direction and magnitude of any change in SAR depend on the configuration and assessment conditions. An increase in local SAR does not, by itself, establish that a device exceeds an applicable regulatory limit.</p>



<p class="wp-block-paragraph">Research by Whittow and colleagues illustrates this complexity. Their 2008 numerical study examined a mobile phone positioned in the front trouser pocket of a truncated male anatomical body model. Using a finite-difference time-domain (FDTD) method, the researchers investigated frequencies from 0.9 to 4 GHz and introduced three everyday metallic objects into the model: a coin, a ring and a zip.</p>



<p class="wp-block-paragraph">The researchers reported that these objects increased SAR in the body at certain frequencies. The combined effect of all three objects generally increased SAR in the waist section across the frequency range studied. However, the findings relate to the specific objects, phone configuration and numerical model investigated; they should not be assumed to apply directly to every commercial phone case or belt clip.</p>



<p class="wp-block-paragraph"><strong>Research source:</strong> Whittow et al. (2008), <em>Indicative SAR Levels Due to an Active Mobile Phone in a Front Trouser Pocket in Proximity to Common Metallic Objects</em>.<strong> <a href="https://doi.org/10.1109/LAPC.2008.4516888">https://doi.org/10.1109/LAPC.2008.4516888</a></strong></p>



<p class="wp-block-paragraph"><strong>Published in:</strong> <a href="https://ieeexplore.ieee.org/xpl/conhome/4509975/proceeding">2008 Loughborough Antennas and Propagation Conference</a> (conference paper).</p>



<h3 class="wp-block-heading">Metal Can Also Affect Antenna Performance</h3>



<p class="wp-block-paragraph">A smartphone antenna operates within a carefully designed electromagnetic environment. Nearby conductive materials can alter antenna impedance, tuning, radiation patterns and efficiency. The effects depend on the device, the material’s electrical properties and its position and geometry.</p>



<p class="wp-block-paragraph">Changes in antenna performance can affect a phone’s radio link and may influence its transmit-power control under some operating conditions. However, the presence of a metal accessory does not, by itself, establish that a phone will transmit at maximum power or that RF exposure will increase. The outcome also depends on network conditions and the phone’s power-control mechanisms.</p>



<h3 class="wp-block-heading">Specially Designed Metal Structures Can Produce Different Results</h3>



<p class="wp-block-paragraph">Not all metallic structures have the same effect. Researchers have investigated specially engineered structures designed to reduce SAR under specific test conditions. </p>



<p class="wp-block-paragraph">For example, Sufian and Hussain published a 2024 study of a commercially available phone case modified by printing a slotted metallic metasurface onto it. Using a mannequin model resembling a human head, the researchers measured a reduction in SAR from 1.387 W/kg to 0.985 W/kg. The authors reported a reduction of more than 26%.</p>



<p class="wp-block-paragraph">This was a purpose-designed metallic structure, not an ordinary metal case or belt clip. The findings therefore cannot be generalised to commercially available accessories simply because they contain metal.</p>



<p class="wp-block-paragraph"><strong>Research source:</strong> Sufian, A. and Hussain, N. (2024), <em>Metasurface-Based Phone Case for the SAR Reduction of the 5G Mobile Phones</em>. <a href="https://doi.org/10.1109/TEMC.2023.3348110"><strong>https://doi.org/10.1109/TEMC.2023.3348110</strong></a></p>



<h3 class="wp-block-heading">What Does FCC Guidance Say About Metal Components in Body-Worn Accessories?</h3>



<p class="wp-block-paragraph">The US Federal Communications Commission (FCC) publishes guidance on assessing radiofrequency (RF) exposure from mobile and portable devices. This guidance describes procedures used to evaluate compliance with applicable RF-exposure requirements as part of the equipment-authorisation process.</p>



<p class="wp-block-paragraph">For body-worn use, the relevant assessment conditions may include the position of the device, its distance from the body and the accessory configuration. Smartphone manufacturers may therefore specify minimum separation distances or advise against using accessories containing metal for particular models.</p>



<p class="wp-block-paragraph">Users should follow the RF-exposure instructions provided for their specific phone.</p>



<p class="wp-block-paragraph"><a href="https://apps.fcc.gov/oetcf/kdb/forms/FTSSearchResultPage.cfm?id=20676&amp;switch=P"><strong>Source:</strong> <strong>FCC KDB Publication 447498 — Mobile and Portable Device RF Exposure, Equipment Authorisation Procedures</strong></a></p>



<h2 class="wp-block-heading">International Standards for RF-Exposure Assessment</h2>



<p class="wp-block-paragraph">The International Telecommunication Union (ITU-T) approved Recommendation K.160 in December 2025. It provides guidance on assessing human exposure to radiofrequency (RF) electromagnetic fields from wireless communication devices operating close to the body, including mobile phones. The recommendation addresses compliance assessment using Specific Absorption Rate (SAR) and absorbed power density (APD), as well as reference levels for incident power density (IPD).</p>



<p class="wp-block-paragraph"><strong>Source</strong>: <a href="https://www.itu.int/rec/T-REC-K.160/en"><strong>ITU-T K.160 — Assessment of Human Exposure to Radiofrequency Electromagnetic Fields from Wireless Communication Devices Operating Close to the Human Body</strong></a></p>



<p class="wp-block-paragraph">The International Electrotechnical Commission (IEC) and the Institute of Electrical and Electronics Engineers (IEEE) jointly publish IEC/IEEE 62209-1528, an international standard specifying procedures for measuring SAR from handheld and body-mounted wireless communication devices. It covers use near the head and body, including configurations involving accessories such as belt clips. Amendment 1 to the 2020 edition was published in September 2026.</p>



<p class="wp-block-paragraph"><strong>Source: <a href="https://webstore.iec.ch/en/publication/116521">IEC/IEEE 62209-1528 — SAR Measurement Procedure</a></strong></p>



<h3 class="wp-block-heading">European Update: Changes to SAR and RF-Exposure Testing</h3>



<p class="wp-block-paragraph">In November 2025, the Netherlands Standardization Institute (NEN) published amendment EN 50566:2017/A2:2025 to the European standard for assessing RF-exposure compliance in handheld and body-mounted wireless communication devices. On 4 September 2026, the European Commission adopted Implementing Decision (EU) 2026/2003, published in the Official Journal of the European Union on 7 September 2026. The decision includes EN 50566:2017, as amended by A1:2023 and A2:2025, in the list of harmonised standards under the EU Radio Equipment Directive. The references to the earlier standard and A1:2023 are scheduled to be withdrawn on 7 March 2028.</p>



<p class="wp-block-paragraph">The decision updates the EU&#8217;s harmonised standards framework for demonstrating conformity with applicable RF-exposure requirements under the Radio Equipment Directive. The 7 March 2028 date allows a transition period before the references to EN 50566:2017 and amendment A1:2023 are withdrawn from the Official Journal of the European Union.</p>



<p class="wp-block-paragraph"><strong>Sources:</strong></p>



<ul class="wp-block-list">
<li><strong><a href="https://www.nen.nl/en/nen-en-50566-2017-a2-2025-en-344126">NEN — EN 50566:2017/A2:2025</a></strong></li>



<li><a href="https://eur-lex.europa.eu/eli/dec_impl/2026/2003/oj"><strong>European Commission — Implementing Decision (EU) 2026/2003</strong></a></li>
</ul>



<h3 class="wp-block-heading">Examples of Manufacturer Compliance Instructions</h3>



<p class="wp-block-paragraph">The following examples illustrate how manufacturers address metallic components and separation distances in their RF-exposure guidance. The instructions differ by device and, in some cases, by jurisdiction.</p>



<h3 class="wp-block-heading">Google — Pixel 10, Pixel 10 Pro and Pixel 10 Pro XL</h3>



<p class="wp-block-paragraph"><strong>Body-worn use and separation distance:</strong> Google&#8217;s Safety and Regulatory Guide specifies that, in countries where the SAR limit is 1.6 W/kg averaged over 1 gram of tissue, body-worn use must provide at least 1.0 cm (10 mm; 0.4 inches) of separation between the device and the user&#8217;s body. It also restricts body-worn use to protective cases, holsters, armbands or similar accessories that contain no metallic components in their assembly. Consult the guide for the applicable device and jurisdiction.</p>



<p class="wp-block-paragraph"><strong>Primary source: <a href="https://support.google.com/pixelphone/answer/16275254?hl=en-GB">Google Pixel 10 series — Safety and regulatory guide</a></strong></p>



<h3 class="wp-block-heading">Apple — Metal Components in Specific iPhone Cases </h3>



<p class="wp-block-paragraph">Apple cautions that cases containing metal may affect an iPhone&#8217;s RF performance and compliance with RF-exposure guidelines, and states that this configuration has not been tested or certified.</p>



<p class="wp-block-paragraph"><strong>Primary source: <a href="https://regulatoryinfo.apple.com/rfexposure/iphone14%2C5/en">Apple — iPhone RF Exposure Information (models A2482, A2631, A2633, A2634 and A2635)</a></strong></p>



<h3 class="wp-block-heading">Xiaomi — Redmi Note 8 Pro</h3>



<p class="wp-block-paragraph">Xiaomi’s official Redmi Note 8 Pro user guide provides SAR information for body-worn use, including a minimum separation distance of 5 mm. It also advises users to choose belt clips or holsters without metallic components.</p>



<p class="wp-block-paragraph">In its US FCC-related guidance, Xiaomi states that RF-exposure compliance has not been tested or certified for body-worn accessories containing metal and advises users to avoid such accessories. The US guidance specifies a minimum separation distance of 1.5 cm for the described body-worn configuration.</p>



<p class="wp-block-paragraph"><strong>Primary source:</strong> <strong><a href="https://www.mi.com/global/support/user-guide-pdf/il/redmi-note-8-pro/">Xiaomi Redmi Note 8 Pro user guide</a></strong></p>



<h3 class="wp-block-heading">Xiaomi — 15T Pro</h3>



<p class="wp-block-paragraph">Xiaomi’s official 15T Pro user guide specifies a minimum separation distance of 5 mm for the described body-worn SAR compliance conditions. It recommends using a belt clip or holster without metallic components.</p>



<p class="wp-block-paragraph">The guide also states that RF-exposure compliance has not been tested or certified for body-worn accessories containing metal and advises users to avoid them. </p>



<p class="wp-block-paragraph"><strong>Primary source:</strong> <a href="https://www.mi.com/my/support/user-guide-pdf/xiaomi-15t-pro/"><strong>Xiaomi 15T Pro user guide</strong></a></p>



<h3 class="wp-block-heading">Huawei — P30</h3>



<p class="wp-block-paragraph">Huawei’s official P30 regulatory information for the Australian market states that the phone complies with applicable RF specifications when used near the ear or at a distance of 0.5 cm from the body. It also instructs users to ensure that accessories, including phone cases and holsters, do not contain metal components.</p>



<p class="wp-block-paragraph"><strong>Primary source:</strong> <a href="https://consumer.huawei.com/au/phones/p30/information/"><strong>Huawei P30 — regulatory information</strong></a></p>



<h3 class="wp-block-heading">What Consumers Should Know</h3>



<p class="wp-block-paragraph">Metal components in body-worn accessories can affect the electromagnetic field around a transmitting smartphone. The effects depend on the device, the material, its position and the operating conditions.</p>



<p class="wp-block-paragraph">Manufacturer instructions matter because RF-exposure compliance assessments are conducted under specified test conditions and configurations. Compliance should not automatically be assumed for accessory configurations that fall outside those assessed or specified by the manufacturer.</p>



<p class="wp-block-paragraph">If you carry your phone close to your body, consult the manufacturer&#8217;s guidance for your specific model, follow the stated separation distance, and choose accessories that comply with the manufacturer&#8217;s instructions. These steps help consumers make informed decisions based on documented testing conditions, without implying that all metal accessories are unsafe or that guidance for one accessory or device necessarily applies to another.</p>



<p class="wp-block-paragraph">This article summarises published research, technical standards and manufacturer guidance for general information. It is not a product-specific RF-exposure assessment or legal advice.</p>



<p class="wp-block-paragraph"><strong>Related: <a href="https://www.emfsa.co.za/research-and-studies/from-research-and-regulation-to-corporate-and-insurance-risk/">From Research and Regulation to Corporate and Insurance Risk</a></strong></p>



<h6 class="wp-block-heading">EMFSA | 13 October 2026</h6>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph"></p>
<p>The post <a href="https://www.emfsa.co.za/safety/metal-components-in-body-worn-accessories/">Metal Components in Body-Worn Accessories: Smartphone Compliance Guidance</a> appeared first on <a href="https://www.emfsa.co.za">EMFSA</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>From Research and Regulation to Corporate and Insurance Risk</title>
		<link>https://www.emfsa.co.za/research-and-studies/from-research-and-regulation-to-corporate-and-insurance-risk/</link>
		
		<dc:creator><![CDATA[Editor]]></dc:creator>
		<pubDate>Tue, 29 Sep 2026 13:49:55 +0000</pubDate>
				<category><![CDATA[Research and Studies]]></category>
		<category><![CDATA[Corporate Risk]]></category>
		<category><![CDATA[Insurance]]></category>
		<category><![CDATA[Regulation]]></category>
		<category><![CDATA[Telecommunications]]></category>
		<guid isPermaLink="false">https://www.emfsa.co.za/?p=32600</guid>

					<description><![CDATA[<p>From Research and Regulation to Corporate and Insurance Risk Research and regulation are increasingly intersecting with questions surrounding electromagnetic fields (EMF) and radiofrequency (RF) radiation. What happens when questions about scientific evidence and exposure standards extend into regulation, corporate governance, litigation and financial risk? The September 2026 EMFSA newsletter considers some of those connections. EMFSA [&#8230;]</p>
<p>The post <a href="https://www.emfsa.co.za/research-and-studies/from-research-and-regulation-to-corporate-and-insurance-risk/">From Research and Regulation to Corporate and Insurance Risk</a> appeared first on <a href="https://www.emfsa.co.za">EMFSA</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<h1 class="wp-block-heading">From Research and Regulation to Corporate and Insurance Risk</h1>



<p class="wp-block-paragraph">Research and regulation are increasingly intersecting with questions surrounding electromagnetic fields (EMF) and radiofrequency (RF) radiation.<strong> </strong>What happens when questions about scientific evidence and exposure standards extend into regulation, corporate governance, litigation and financial risk?</p>



<p class="wp-block-paragraph">The September 2026 EMFSA newsletter considers some of those connections.</p>



<p class="wp-block-paragraph"><strong>EMFSA | 29 September 2026</strong></p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="742" src="https://www.emfsa.co.za/wp-content/uploads/2026/09/emf-rf-research-regulation-and-risk-1024x742.png" alt="Venn diagram showing the intersection of EMF/RF research, regulation, and corporate insurance risk with three overlapping circles." class="wp-image-32599" srcset="https://www.emfsa.co.za/wp-content/uploads/2026/09/emf-rf-research-regulation-and-risk-1024x742.png 1024w, https://www.emfsa.co.za/wp-content/uploads/2026/09/emf-rf-research-regulation-and-risk-300x218.png 300w, https://www.emfsa.co.za/wp-content/uploads/2026/09/emf-rf-research-regulation-and-risk-768x557.png 768w, https://www.emfsa.co.za/wp-content/uploads/2026/09/emf-rf-research-regulation-and-risk-1536x1114.png 1536w, https://www.emfsa.co.za/wp-content/uploads/2026/09/emf-rf-research-regulation-and-risk.png 1600w" sizes="auto, (max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">EMF/RF sits at the convergence of research findings, regulatory frameworks, and corporate insurance risk considerations.<br></figcaption></figure>



<h3 class="wp-block-heading">What is changing in the research and regulatory landscape?</h3>



<p class="wp-block-paragraph">Several recent developments in the United States and France are putting renewed attention on radiofrequency radiation and health, but they are taking different forms.</p>



<p class="wp-block-paragraph">In the United States, federal agencies are seeking public input on questions ranging from the evidence for potential health effects to exposure levels, research gaps and the scientific basis for existing approaches. The FCC proceeding also raises detailed questions about the quality and interpretation of the evidence, including study design, exposure assessment, dosimetry, confounding and the distinction between association and causation.</p>



<p class="wp-block-paragraph">What questions are being asked about the evidence? What research gaps have been identified? And how might future research inform regulatory discussions?</p>



<p class="wp-block-paragraph">In France, ANSES is approaching the subject through a call intended to support new research into radiofrequencies and health.</p>



<p class="wp-block-paragraph">These developments are examined in greater detail in <strong><a href="https://www.emfsa.co.za/news/electromagnetic-fields-and-radiofrequency-radiation-u-s-hhs-seeks-public-input-france-calls-for-new-research/">Electromagnetic Fields and Radiofrequency Radiation: U.S. HHS Seeks Public Input; France Calls for New Research</a>.</strong></p>



<h2 class="wp-block-heading">What does telecommunications infrastructure mean for corporate risk?</h2>



<p class="wp-block-paragraph">Telecommunications networks operate within complex regulatory and commercial environments. Infrastructure and licensing are only part of the picture.</p>



<p class="wp-block-paragraph">What happens when market access or regulatory decisions involve government officials or politically connected intermediaries? What controls are needed around third-party payments? How can companies manage risks associated with corporate governance, compliance and anti-bribery obligations?</p>



<p class="wp-block-paragraph">These questions are particularly relevant to telecommunications companies operating across multiple jurisdictions, where local regulatory requirements may intersect with foreign anti-corruption and anti-bribery laws.</p>



<p class="wp-block-paragraph"><strong><a href="https://www.emfsa.co.za/news/telecommunications-infrastructure-and-corporate-risk/">Telecommunications Infrastructure and Corporate Risk</a> </strong>examines these issues and the broader compliance environment surrounding telecommunications infrastructure.</p>



<h2 class="wp-block-heading">Who ultimately bears the financial risk?</h2>



<p class="wp-block-paragraph">A different set of questions arises when EMF/RF issues become the subject of litigation.</p>



<p class="wp-block-paragraph">If a claim continues for years, who pays the cost of defending it? If a company settles a claim or is ultimately found liable, does its insurance respond? What happens when a policy contains exclusions relating to radiation, signal-transmitting equipment or telecommunications infrastructure?</p>



<p class="wp-block-paragraph">Insurance coverage and legal liability are not necessarily the same question. The wording of an insurance policy can determine whether particular risks are transferred to an insurer or remain with the company.</p>



<p class="wp-block-paragraph">These issues are explored in <a href="https://www.emfsa.co.za/news/emf-rf-insurance-who-is-responsible/"><strong>EMF/RF Insurance: Who Is Responsible?</strong></a>, which looks at insurance exclusions, defence costs and the potential allocation of financial risk in EMF/RF-related litigation.</p>



<h2 class="wp-block-heading">Following the connections</h2>



<p class="wp-block-paragraph">Research, regulation, corporate governance, litigation and insurance may appear to be separate subjects. Yet developments in one area can raise questions in another.</p>



<p class="wp-block-paragraph">For EMFSA, following these connections is part of examining the wider implications of electromagnetic fields and radiofrequency radiation — while keeping the focus on evidence, documented developments and the questions that remain open.</p>



<p class="wp-block-paragraph"><a href="https://mailchi.mp/emfsa/emfsa-september-2026-newsletter"><strong>The September 2026 newsletter</strong></a> brings these three strands together, while the individual articles provide a more detailed examination of each subject.</p>



<p class="wp-block-paragraph"></p>
<p>The post <a href="https://www.emfsa.co.za/research-and-studies/from-research-and-regulation-to-corporate-and-insurance-risk/">From Research and Regulation to Corporate and Insurance Risk</a> appeared first on <a href="https://www.emfsa.co.za">EMFSA</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>EMF/RF Insurance: Who Is Responsible?</title>
		<link>https://www.emfsa.co.za/news/emf-rf-insurance-who-is-responsible/</link>
		
		<dc:creator><![CDATA[Editor]]></dc:creator>
		<pubDate>Sun, 27 Sep 2026 16:07:08 +0000</pubDate>
				<category><![CDATA[Legal]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[FCC]]></category>
		<category><![CDATA[HHS]]></category>
		<category><![CDATA[Insurance]]></category>
		<category><![CDATA[RFI]]></category>
		<guid isPermaLink="false">https://www.emfsa.co.za/?p=32483</guid>

					<description><![CDATA[<p>EMF/RF Insurance: Who Is Responsible?&#160; EMF/RF Insurance is an important consideration when assessing the potential financial consequences of alleged RF/EMF exposure. A telecommunications company may carry substantial general liability, product liability, excess and other insurance, but that does not necessarily mean those policies provide coverage for liability arising from alleged health effects of RF/EMF exposure. [&#8230;]</p>
<p>The post <a href="https://www.emfsa.co.za/news/emf-rf-insurance-who-is-responsible/">EMF/RF Insurance: Who Is Responsible?</a> appeared first on <a href="https://www.emfsa.co.za">EMFSA</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<h1 class="wp-block-heading"><strong>EMF/RF Insurance: Who Is Responsible?</strong>&nbsp;<br></h1>



<p class="wp-block-paragraph">EMF/RF Insurance is an important consideration when assessing the potential financial consequences of alleged RF/EMF exposure. A telecommunications company may carry substantial general liability, product liability, excess and other insurance, but that does not necessarily mean those policies provide coverage for liability arising from alleged health effects of RF/EMF exposure.</p>



<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="496" height="245" src="https://www.emfsa.co.za/wp-content/uploads/2026/09/EMF-RF-Insurance.jpg" alt="EMF/RF Insurance: Who Is Responsible?" class="wp-image-32482" style="width:418px;height:auto" srcset="https://www.emfsa.co.za/wp-content/uploads/2026/09/EMF-RF-Insurance.jpg 496w, https://www.emfsa.co.za/wp-content/uploads/2026/09/EMF-RF-Insurance-300x148.jpg 300w" sizes="auto, (max-width: 496px) 100vw, 496px" /><figcaption class="wp-element-caption">Exploring liability allocation when EMF/RF exposure claims fall outside standard insurance coverage.<br><br><strong>EMFSA  | 27 September 2026</strong></figcaption></figure>



<p class="wp-block-paragraph"><a href="https://www.emfsa.co.za/news/telecommunications-infrastructure-and-corporate-risk/">Telecommunications Infrastructure and Corporate Risk</a> examines the broader corporate-risk framework. This article considers EMF/RF exclusions, litigation, corporate disclosures and retained/uninsured risk. </p>



<h3 class="wp-block-heading"><strong>Defence Costs and Liability: Two Different Questions&nbsp;</strong></h3>



<p class="wp-block-paragraph">If a telecom company faces a long-running RF health claim, there are two quite separate financial questions:</p>



<ul class="wp-block-list">
<li>What does it cost the company to defend the litigation?</li>
</ul>



<ul class="wp-block-list">
<li>If the company loses, or settles, who ultimately bears the liability?</li>
</ul>



<p class="wp-block-paragraph">An EMF exclusion could potentially mean that the second risk is retained by the company, rather than transferred to its liability insurer. Depending on the policy wording, even defence costs may be affected.<br></p>



<h3 class="wp-block-heading"><strong>The distinction between “insured litigation risk” and “retained/uninsured litigation risk”</strong></h3>



<p class="wp-block-paragraph">One cannot assume that because an insurer excludes EMF bodily-injury liability, all costs associated with an RF lawsuit are uninsured. Other policies, coverages, retentions, contractual indemnities and defence provisions can change the picture. Actual<strong> </strong>policy wording<strong> </strong>shows that EMF-related liability may be specifically carved out of liability insurance.</p>



<h4 class="wp-block-heading">I<strong>nsurance Exclusions Can Limit Coverage&nbsp;</strong></h4>



<p class="wp-block-paragraph">Existing policy exclusions may limit insurers&#8217; exposure to EMF/RF-related liability.</p>



<p class="wp-block-paragraph"><strong>Example from a South African Policy Wording&nbsp;</strong></p>



<p class="wp-block-paragraph">A South African insurance policy wording also demonstrates that electromagnetic-radiation risks can be expressly excluded from liability coverage. For example, the <a href="https://jvcinsurance.co.za/wp-content/uploads/2024/09/ITOO-General-Liability-Insurance-Policy-Wording.pdf">iTOO General Liability Insurance Policy Wording</a> contains an “Electromagnetic Radiation” exclusion addressing liability arising from signal-transmitting lines and towers, including cellular towers, as well as devices including cellular phones and antennas. </p>



<h4 class="wp-block-heading">Broad radiation<strong> exclusions can encompass non-ionising EMF</strong></h4>



<p class="wp-block-paragraph">An insurance policy can exclude liability for alleged EMF-related injury even where the exclusion is framed as a “radioactive matter” or “radiation” exclusion. An example is the Hammond Power Solutions case. The Seventh Circuit held that, under Wisconsin law, an insurance exclusion covering exposure to “any form of radiation” encompassed the alleged EMF radiation from transformers. The court expressly said that the parties agreed that EMFs qualified as radiation for purposes of the case. It was an insurance-contract interpretation decision, not a scientific finding about health effects.&nbsp;</p>



<p class="wp-block-paragraph">The case concerned electromagnetic fields associated with electrical transformers rather than RF communications, but it illustrates how broadly worded radiation exclusions can become relevant to non-ionising EMF claims.&nbsp;</p>



<p class="wp-block-paragraph">The Hammond decision demonstrates that the application of a radiation exclusion can itself become the subject of coverage litigation. <a href="https://content.govdelivery.com/accounts/USFEDCOURTS/bulletins/3e8667d"><strong>Hammond Power Solutions, Inc. v. National Union Fire Insurance Company of Pittsburg No. 24-1642</strong></a></p>



<h4 class="wp-block-heading">HHS and the FCC are now seeking public input through separate proceedings concerning RF exposure </h4>



<p class="wp-block-paragraph">HHS is seeking evidence on potential health effects, including effects associated with exposure below current federal limits, cumulative exposure, existing standards, research gaps and possible improvements to assessment and regulation. The FCC&#8217;s proceeding addresses the RF-exposure issues arising from the D.C. Circuit&#8217;s 2021 remand.&nbsp;</p>



<h3 class="wp-block-heading"><strong>Questions for the Insurance and Liability Analysis</strong></h3>



<ul class="wp-block-list">
<li>How do telecommunications companies, insurers and other risk-bearing arrangements currently allocate RF-related liability? What could change if the scientific or regulatory position changes?</li>



<li>If commercial liability policies exclude or potentially exclude RF/EMF-related health liability, how are telecommunications companies managing that risk?</li>



<li>What, if anything, can be learned from the industry&#8217;s public response to the HHS RFI and FCC proceeding about how companies currently assess, transfer or retain RF/EMF-related health risks?</li>
</ul>



<h3 class="wp-block-heading"><strong>Corporate Risk Allocation: Who Ultimately Bears the Cost?&nbsp;</strong></h3>



<p class="wp-block-paragraph">What do companies disclose about their own insurance?</p>



<ul class="wp-block-list">
<li><a href="https://investor.crowncastle.com/sec-filings/sec-filing/10-k/0001051470-26-000016">Crown Castle&#8217;s 2025 Form 10-K </a> states that if a connection between RF emissions and adverse health effects were established, its operations, costs or revenues could be materially and adversely affected. It also states: &#8220;We currently do not maintain any significant insurance with respect to these matters.&#8221;</li>



<li><a href="https://www.sec.gov/Archives/edgar/data/732712/000073271226000015/a2025_aronform10-k.pdf">Verizon&#8217;s current 2025 Form 10-K</a> says that its wireless business is subject to lawsuits concerning alleged adverse health effects of wireless phones and RF transmitters. It says the company may incur significant expenses defending such lawsuits and may face significant damages or settlements. It also says changes in government agencies&#8217; assessment of wireless-device risks could result in significant legal and regulatory liability and materially affect the company. Note that Verizon&#8217;s disclosure does not say that these liabilities are uninsured.</li>
</ul>



<h3 class="wp-block-heading">Manufacturer RF-Exposure Instructions</h3>



<p class="wp-block-paragraph">Smartphone manufacturers also provide users with specific RF-exposure instructions, including separation distances for body-worn use.</p>



<p class="wp-block-paragraph">Google — <a href="https://support.google.com/pixelphone/answer/16275254">current Pixel 10 regulatory guide</a></p>



<p class="wp-block-paragraph">Google&#8217;s official safety and regulatory guide states that body-worn operation requires 1.0 cm (10 mm) separation for Pixel 10, Pixel 10 Pro and Pixel 10 Pro XL models in U.S. 1.6 W/kg SAR jurisdictions. It also states that body-worn accessories should not contain metallic components.</p>



<p class="wp-block-paragraph">Samsung — <a href="https://www.samsung.com/us/support/legal/LGL10000282/">official RF/SAR information</a></p>



<p class="wp-block-paragraph">Samsung’s official information states that SAR certification establishes a minimum recommended distance from a person’s body for operation of RF-emitting devices, and specifies 15 mm for phones.</p>



<p class="wp-block-paragraph">These manufacturer instructions are relevant to the broader liability question because they document specific conditions and separation distances associated with RF-emitting products, although they do not by themselves establish that ordinary use causes harm or give rise to liability.</p>



<h3 class="wp-block-heading"><strong>RF-Related Litigation Can Create Long-Term Financial Exposure&nbsp;</strong></h3>



<p class="wp-block-paragraph">The more-than-two-decade <em><strong><a href="https://law.justia.com/cases/district-of-columbia/court-of-appeals/2025/23-cv-0700.html">Murray v. Motorola</a></strong></em> litigation illustrates how RF-related claims can generate prolonged litigation, expert proceedings, discovery and appeals. In a July 2025 decision, the D.C. Court of Appeals affirmed summary judgment for the defendants following the exclusion of the plaintiffs’ expert testimony under Rule 702. Although <em>Murray</em> is not an insurance-coverage dispute, its lengthy history shows how RF-related claims can create potentially significant long-term litigation costs and financial exposure.</p>



<h3 class="wp-block-heading"><strong>What Could Change if the Regulatory Position Changes?</strong></h3>



<ul class="wp-block-list">
<li>At least one wireless-infrastructure company publicly discloses that it does not maintain significant insurance with respect to potential RF-related health risks.</li>



<li>A change in the regulatory or scientific environment could create additional compliance, operational or financial exposure.&nbsp;</li>



<li>RF-related public concerns can have consequences beyond litigation, including potential effects on deployment and market acceptance.</li>
</ul>



<h4 class="wp-block-heading"><strong>An RFI could potentially become relevant to insurance even if existing policies contain exclusions.</strong></h4>



<p class="wp-block-paragraph">For example, scientific or regulatory developments could lead to:</p>



<ul class="wp-block-list">
<li>new insurance products;</li>



<li>altered underwriting;</li>



<li>changes in exclusions;</li>



<li>disputes over existing wording;</li>



<li>changes in corporate insurance purchasing;</li>



<li>changes in captive/self-insurance arrangements; or</li>



<li>increased attention to potential residual exposures.</li>
</ul>



<h4 class="wp-block-heading">We don&#8217;t know yet what the endpoint will be:</h4>



<ul class="wp-block-list">
<li>an HHS advisory;</li>



<li>new warnings;</li>



<li>Wi-Fi restrictions in schools;</li>



<li>recommendations to parents;</li>



<li>stricter consumer-electronics labelling.</li>
</ul>



<p class="wp-block-paragraph">These are <strong>illustrative possibilities, not predictions or established endpoints</strong>. The outcome of the HHS review is not yet known.</p>



<h3 class="wp-block-heading"><strong>The FCC and RF Exposure Limits: From 2013 to 2026</strong></h3>



<h4 class="wp-block-heading">2013–2019: The FCC’s Review of RF Exposure Limits&nbsp;</h4>



<p class="wp-block-paragraph"><br>The history is significant. The FCC opened <a href="https://www.fcc.gov/document/fcc-review-rf-exposure-policies"><strong>a science-based inquiry</strong></a> into the adequacy of its RF exposure limits in 2013 and stated that it would work closely with federal agencies with relevant health expertise. In 2019, the FCC <a href="https://docs.fcc.gov/public/attachments/FCC-19-126A1_Rcd.pdf"><strong>concluded that the record did not provide an adequate basis for changing the limits</strong></a> and terminated the inquiry.</p>



<h4 class="wp-block-heading">2021: The D.C. Circuit Remand</h4>



<p class="wp-block-paragraph"><a href="https://media.cadc.uscourts.gov/opinions/docs/2021/08/20-1025-1910111.pdf"><strong>In 2021, however, the D.C. Circuit remanded the FCC&#8217;s decision</strong></a>. The court found that the FCC had failed to provide a reasoned explanation for its determination that its RF exposure limits were adequately protective against harmful effects of RF exposure unrelated to cancer. This failure undermined the FCC&#8217;s conclusions concerning the adequacy of its testing procedures, particularly as they related to children. It also affected the agency&#8217;s conclusions concerning long-term exposure, RF pulsation or modulation, and technological developments since 1996. In addition, the court found that the FCC had failed to respond adequately to comments concerning environmental harm from RF radiation.&nbsp;<br></p>



<p class="wp-block-paragraph">The court&#8217;s decision did not determine that RF exposure causes these effects, nor did it conclude that the FCC&#8217;s exposure limits were scientifically unsafe. Rather, it held that the FCC had not adequately explained its conclusions in response to the evidence and comments before it. The court also upheld the FCC&#8217;s explanation concerning cancer. The remand therefore focused on the agency&#8217;s treatment of potential harmful effects unrelated to cancer.&nbsp;</p>



<h4 class="wp-block-heading">2026: The FCC Reopens the Remand Issues<br></h4>



<p class="wp-block-paragraph">On <a href="https://docs.fcc.gov/public/attachments/DA-26-997A1.pdf"><strong>17 September 2026, the FCC issued a new Public Notice seeking comment on the RF exposure issues subject to the D.C. Circuit&#8217;s remand</strong></a> in Environmental Health Trust v. FCC. The proceeding concerns the issues that remained unresolved following the court&#8217;s 2021 decision.</p>



<p class="wp-block-paragraph">The HHS RFI and the FCC proceeding are therefore related but distinct. HHS is seeking information on scientific evidence, exposure, health effects, research gaps and possible recommendations, while the FCC proceeding addresses the RF-exposure issues arising from its own regulatory proceeding and the D.C. Circuit&#8217;s remand.</p>



<h3 class="wp-block-heading"><strong>What Does the HHS RFI Change?</strong>&nbsp;</h3>



<p class="wp-block-paragraph">HHS can conduct health research, issue public-health information and make recommendations within its statutory authority. The FCC&#8217;s regulatory authority over RF exposure limits is a separate question.</p>



<p class="wp-block-paragraph">The HHS RFI does not change federal RF exposure limits or impose new requirements on the telecommunications industry. It does, however, establish an official process for examining the scientific evidence, real-world exposure, existing standards, research gaps and potential health effects, including exposures below current federal limits. HHS states that the information received may inform future research, funding solicitations or policies. For a broader examination of the HHS RFI, the current U.S. process and France&#8217;s parallel call for new RF research, see <a href="https://www.emfsa.co.za/news/electromagnetic-fields-and-radiofrequency-radiation-u-s-hhs-seeks-public-input-france-calls-for-new-research/"><strong>Electromagnetic Fields and Radiofrequency Radiation: U.S. HHS Seeks Public Input; France Calls for New Research</strong>.</a> </p>



<h4 class="wp-block-heading"><strong>Future Litigation: Could the Evidence Base Change?</strong></h4>



<p class="wp-block-paragraph">The HHS RFI could become relevant to future litigation if it leads to new research, additional evidence or changes in the regulatory or scientific assessment of RF exposure. HHS is specifically seeking information on potential health effects, including effects associated with exposure below current federal limits, as well as research gaps and priorities for future federal research.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Generating New Evidence</strong></p>



<p class="wp-block-paragraph">If the RFI contributes to new federally supported research or identifies important research gaps that are subsequently addressed, the resulting evidence could become relevant to future litigation. Whether particular studies would be admissible or persuasive would depend on the evidence itself and the applicable evidentiary rules.</p>



<p class="wp-block-paragraph"><strong>Regulatory Changes Could Affect Future Preemption Arguments</strong></p>



<p class="wp-block-paragraph">Federal preemption has also been an important issue in RF-related litigation. Courts have, in some circumstances, held that federal RF regulations preempt state-law claims concerning devices that comply with <a href="https://law.justia.com/cases/district-of-columbia/court-of-appeals/2009/07-cv-1074-5.html"><strong>FCC exposure requirements</strong></a>. The scope and basis of preemption, however, depend on the particular claims and applicable law.</p>



<p class="wp-block-paragraph">If future federal action were to materially alter the applicable RF exposure standards or the regulatory framework underlying those decisions, parties in later litigation could potentially argue about what effect those changes have on existing preemption principles. That would be a legal question for the courts; a change in federal health policy would not automatically eliminate preemption defenses.</p>



<h3 class="wp-block-heading"><strong>Industry Response Is Still Developing</strong></h3>



<p class="wp-block-paragraph">As of 27 September 2026, we have not identified detailed public responses from major telecommunications or technology companies specifically addressing the HHS RFI. At the same time, the <a href="https://docs.fcc.gov/public/attachments/DA-26-997A1.pdf">FCC&#8217;s September 2026</a> notice reflects the continuing importance of 5G, 6G and spectrum development within U.S. communications policy. HHS has invited industry stakeholders to provide evidence on exposure standards, wireless infrastructure, antenna density and small-cell deployment. The industry&#8217;s formal submissions to the RFI may therefore provide important insight into how the sector assesses the potential regulatory and liability implications of the review. </p>



<h6 class="wp-block-heading"><strong>Related EMFSA articles:</strong></h6>



<ul class="wp-block-list">
<li><a href="https://www.emfsa.co.za/news/emfsa-environmental-health-update-july-2026/">July Environmental Health Update </a></li>
</ul>



<h6 class="wp-block-heading"><strong>Legal Disclaimer</strong>: </h6>



<p class="wp-block-paragraph">This article is provided for general information and educational purposes only. It does not constitute legal, insurance, financial or professional advice. Insurance coverage depends on the wording, terms, conditions, exclusions and circumstances of the individual policy, as well as applicable law. References to court cases, insurance policies and corporate disclosures are provided for informational purposes and should not be taken as conclusions about the coverage or liability of any particular company or insurer.&nbsp;</p>



<h6 class="wp-block-heading"><strong>AI Disclosure:</strong> </h6>



<p class="wp-block-paragraph">AI tools helped prepare this article through language editing, formatting, editorial assistance and research-support tasks. The author reviewed the sources and factual claims, reviewed and approved the final article, and remains responsible for its accuracy, interpretation and presentation.</p>



<p class="wp-block-paragraph"><br></p>
<p>The post <a href="https://www.emfsa.co.za/news/emf-rf-insurance-who-is-responsible/">EMF/RF Insurance: Who Is Responsible?</a> appeared first on <a href="https://www.emfsa.co.za">EMFSA</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Telecommunications Infrastructure and Corporate Risk</title>
		<link>https://www.emfsa.co.za/news/telecommunications-infrastructure-and-corporate-risk/</link>
		
		<dc:creator><![CDATA[Editor]]></dc:creator>
		<pubDate>Wed, 23 Sep 2026 15:41:35 +0000</pubDate>
				<category><![CDATA[Legal]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Corporate Risk]]></category>
		<category><![CDATA[Corruption]]></category>
		<category><![CDATA[Human Rights]]></category>
		<category><![CDATA[Surveillance]]></category>
		<guid isPermaLink="false">https://www.emfsa.co.za/?p=32398</guid>

					<description><![CDATA[<p>Telecommunications Infrastructure and Corporate Risk Telecommunications Infrastructure and Corporate Risk can take very different forms — including sanctions, surveillance, corruption, government demands for data or network access, allegations arising from armed conflict, and human-rights litigation.&#160; Companies operating in politically unstable, conflict-affected or highly regulated environments can face significant legal, regulatory, reputational and financial risks arising [&#8230;]</p>
<p>The post <a href="https://www.emfsa.co.za/news/telecommunications-infrastructure-and-corporate-risk/">Telecommunications Infrastructure and Corporate Risk</a> appeared first on <a href="https://www.emfsa.co.za">EMFSA</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<h3 class="wp-block-heading">Telecommunications Infrastructure and Corporate Risk</h3>



<p class="wp-block-paragraph">Telecommunications Infrastructure and Corporate Risk can take very different forms — including sanctions, surveillance, corruption, government demands for data or network access, allegations arising from armed conflict, and human-rights litigation.&nbsp;</p>



<p class="wp-block-paragraph">Companies operating in politically unstable, conflict-affected or highly regulated environments can face significant legal, regulatory, reputational and financial risks arising from the environment in which they operate.&nbsp;</p>



<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="960" height="540" src="https://www.emfsa.co.za/wp-content/uploads/2026/09/TELECOMMUNICATIONS-INFRASTRUCTURE.jpg" alt="Text black on white with the words TELECOMMUNICATIONS INFRASTRUCTURE AND CORPORATE RISK as a heading. Followed by Human-rights allegations, Sanctions Corruption Terrorism-related litigation, Surveillance and Criminal investigations." class="wp-image-32403" srcset="https://www.emfsa.co.za/wp-content/uploads/2026/09/TELECOMMUNICATIONS-INFRASTRUCTURE.jpg 960w, https://www.emfsa.co.za/wp-content/uploads/2026/09/TELECOMMUNICATIONS-INFRASTRUCTURE-300x169.jpg 300w, https://www.emfsa.co.za/wp-content/uploads/2026/09/TELECOMMUNICATIONS-INFRASTRUCTURE-768x432.jpg 768w" sizes="auto, (max-width: 960px) 100vw, 960px" /></figure>



<p class="wp-block-paragraph">EMFSA | 23 September 2026</p>



<p class="wp-block-paragraph">This article aims to distinguish between allegations, investigations, regulatory findings, court judgments, settlements and admissions. Where we discuss allegations, we attribute them to the relevant source and identify the legal or investigative status of each case where known.</p>



<p class="wp-block-paragraph">We examine:</p>



<ul class="wp-block-list">
<li>Operations in armed-conflict zones</li>



<li>Allegations of complicity in human-rights abuses</li>



<li>Civil litigation and criminal investigations</li>



<li>Government demands for customer data or network access</li>



<li>Surveillance and law-enforcement capabilities</li>



<li>Sanctions and export-control violations</li>



<li>Corruption and politically connected business relationships</li>
</ul>



<h3 class="wp-block-heading">➼<strong>Telenor — Myanmar</strong></h3>



<p class="wp-block-paragraph"><strong>2021–2026 | Customer data, human-rights allegations and investigation</strong></p>



<p class="wp-block-paragraph">Norwegian police opened an investigation into Telenor concerning allegations relating to customer data and possible complicity in crimes against humanity.&nbsp;</p>



<p class="wp-block-paragraph">According to Reuters, Norwegian police are investigating Telenor on suspicion that the telecommunications operator aided and abetted crimes against humanity in Myanmar following the 2021 military coup. Telenor sold its Myanmar business following the coup and completed its exit from the country in March 2022. The company said it was cooperating closely with investigators and would do everything in its power to assist in clarifying the case. <a href="https://www.reuters.com/business/norway-police-investigate-telenor-over-suspected-crimes-against-humanity-myanmar-2026-09-15/"><strong>Reuters, 15 September 2026.</strong></a></p>



<p class="wp-block-paragraph">The Open Society Justice Initiative has a detailed account of the underlying civil litigation. It reports that plaintiffs filed a class action in Norway in April 2026 concerning the disclosure of customer data, and that the Asker and Bærum District Court subsequently allowed the case to proceed as an opt-out class action.<strong> <a href="https://www.justiceinitiative.org/litigation/justice-and-accountability-initiative-v-telenor-asa">Open Society Justice Initiative — Telenor case</a></strong></p>



<h3 class="wp-block-heading">➼MTN — Afghanistan and Iran</h3>



<p class="wp-block-paragraph"><strong>2006–2026 | Anti-Terrorism Act litigation, Iran-related legal issues and U.S. Department of Justice investigation</strong></p>



<p class="wp-block-paragraph">MTN’s operations in Afghanistan and its minority investment in Iran have been the subject of several separate U.S. legal proceedings and, since 2025, a U.S. Department of Justice investigation. These matters involve different allegations, defendants and legal issues. The existence of a complaint, court proceeding or government investigation does not by itself establish that MTN committed the alleged conduct.</p>



<h4 class="wp-block-heading">Afghanistan and the U.S. Anti-Terrorism Act</h4>



<p class="wp-block-paragraph">MTN began operating in Afghanistan in 2006. On 27 December 2019, plaintiffs filed a complaint in the U.S. District Court for the District of Columbia under the U.S. Anti-Terrorism Act (ATA). The plaintiffs brought claims on behalf of American service members and civilians, and their families, who were killed or injured in Afghanistan. MTN Group and MTN Afghanistan were among the defendants.</p>



<p class="wp-block-paragraph">The plaintiffs alleged, among other things, that companies operating in Afghanistan had made protection payments to the Taliban and thereby provided support connected with terrorist attacks. MTN disputed the allegations and sought dismissal, including on jurisdictional and ATA grounds. MTN said it intended to defend its position. <a href="https://www.reuters.com/article/world/mtn-reviewing-allegations-after-being-named-in-us-complaint-idUSKBN1YY0R4/"><strong>Reuters, December 2019; MTN</strong></a></p>



<p class="wp-block-paragraph">One of the resulting proceedings is <em>Cabrera v. Black &amp; Veatch Special Projects Corporation</em>, Civil Action No. 1:19-cv-03833 (D.D.C.). In 2021, a magistrate judge recommended dismissal of the claims against the MTN defendants. In March 2024, the district court allowed the plaintiffs to file a Second Amended Complaint, including a new theory concerning MTN’s investment in Iran. The court also vacated the earlier recommendation and stayed the case pending related proceedings concerning the interpretation of the U.S. Anti-Terrorism Act. <em><a href="https://www.casemine.com/judgement/us/6610d0fa98c8641582fe7895"><strong>Cabrera v. Black &amp; Veatch Special Projects Corp</strong></a></em><a>.</a> CaseMine (March 28, 2024). </p>



<p class="wp-block-paragraph">The <em>Cabrera</em> docket records the case as “Unstayed” on 17 September 2026, indicating that the earlier stay had been lifted.</p>



<p class="wp-block-paragraph">MTN’s 2025 Annual Financial Statements continued to list the Cabrera litigation among its legal matters.</p>



<h4 class="wp-block-heading"><strong>Irancell and Iran</strong></h4>



<p class="wp-block-paragraph">Since 2006, MTN Group has held a 49% minority, non-controlling interest in Irancell. MTN states that Irancell is not under MTN Group&#8217;s operational control. It has also stated that, following the re-imposition of U.S. sanctions in 2018, it has not deployed capital into the Iran business or extracted capital or dividends from it. <a href="https://www.mtn.com/wp-content/uploads/2026/03/MTN-Group-FY-25-Annual-Financial-Statements.pdf"><strong>MTN Group FY2025 Annual Financial Statements</strong></a></p>



<p class="wp-block-paragraph">MTN’s investment in Irancell has also been relevant to separate U.S. legal proceedings.&nbsp;</p>



<p class="wp-block-paragraph">In 2021, Zobay v. MTN Group was filed in the U.S. District Court for the Eastern District of New York. The plaintiffs alleged that MTN&#8217;s business relationships with Iranian entities, including its investment in Irancell, contributed to support for the Islamic Revolutionary Guard Corps and, indirectly, to attacks against Americans in Iraq and Afghanistan. MTN has contested those allegations.</p>



<p class="wp-block-paragraph">On 28 September 2023, the court denied MTN Group Limited’s motion to dismiss the ATA claims, while granting MTN Dubai Limited’s motion to dismiss. MTN subsequently sought permission to appeal. MTN stated that the ruling did not mean that it had lost the case or that the court had found that it had violated the law. <a href="https://caselaw.findlaw.com/court/us-dis-crt-ed-new-yor/115186232.html"><strong>Zobay court decision</strong></a></p>



<p class="wp-block-paragraph">Two related ATA cases, Chand v. MTN and Davis v. MTN Irancell, were filed in the U.S. District Court for the District of Columbia in March 2022. MTN&#8217;s published disclosures describe these cases as involving allegations concerning MTN&#8217;s investment in Irancell and alleged connections to attacks in Iraq and Afghanistan. <a href="https://www.mtn.com/wp-content/uploads/2026/03/MTN-Group-FY-25-Annual-Financial-Statements.pdf"><strong>MTN Group FY2025 Annual Financial Statements</strong></a></p>



<h4 class="wp-block-heading">U.S. Department of Justice investigation — 2025</h4>



<p class="wp-block-paragraph">In August 2025, MTN disclosed that it had been approached through its external U.S. counsel regarding a U.S. Department of Justice grand-jury investigation concerning MTN Group, its former subsidiary in Afghanistan and Irancell.</p>



<p class="wp-block-paragraph">MTN said that it was cooperating with the Department of Justice and voluntarily responding to requests for information. The company also stated that it had not been charged with any violation of law. MTN exited its Afghanistan business in early 2024.</p>



<p class="wp-block-paragraph">MTN’s disclosure makes it clear that the investigation is separate from the civil Anti-Terrorism Act proceedings. MTN has not stated that it has been charged with an offence.</p>



<h4 class="wp-block-heading">U.S.-Origin Technology and Iran</h4>



<p class="wp-block-paragraph">A separate issue concerns the movement of U.S.-origin technology into Iran. In June 2012, Reuters reported that MTN Irancell had obtained U.S.-origin equipment, including products from Sun Microsystems, Hewlett-Packard and Cisco, through a network of technology companies in Iran and the Middle East.</p>



<p class="wp-block-paragraph">In a follow-up investigation published in August 2012, Reuters reported that internal MTN documents appeared to show that MTN employees had discussed ways of obtaining U.S. technology for MTN Irancell despite U.S. sanctions. Reuters reported that the equipment included products from several U.S. technology companies and that MTN denied wrongdoing.</p>



<p class="wp-block-paragraph">These were matters reported by Reuters, rather than a U.S. government enforcement finding that MTN had violated sanctions. The distinction is important: the Reuters reporting described evidence and allegations concerning the procurement of U.S.-origin technology, while MTN denied wrongdoing. The reporting should therefore not be presented as a finding by U.S. authorities that MTN violated sanctions.</p>



<p class="wp-block-paragraph">Reuters, June 2012 — <a href="https://www.reuters.com/jp/article/iran-mtn-sanctions/exclusive-iranian-cell-phone-carrier-obtained-banned-u-s-tech-idINDEE8530FL20120604"><strong>How an Iranian telecom got banned U.S. tech</strong></a><br>Reuters, August 2012 — <a href="https://www.reuters.com/article/world/special-report-documents-detail-how-mtn-funneled-us-technology-to-iran-idUSBRE87T05S/"><strong>How a telecom giant got round sanctions on Iran</strong></a></p>



<h3 class="wp-block-heading">➼Telia — Uzbekistan</h3>



<p class="wp-block-paragraph"><strong>2007–2017 | Corruption, telecommunications licences and international enforcement</strong></p>



<p class="wp-block-paragraph">Telia Company AB&#8217;s operations in Uzbekistan became the subject of a major international foreign-bribery investigation. According to U.S. and Dutch enforcement authorities, Telia and its Uzbek subsidiary, Coscom LLC, paid more than $331 million in bribes between approximately 2007 and 2010 to an Uzbek government official who had influence over the country&#8217;s telecommunications regulator. Telia and Coscom made the payments to enter and expand Telia&#8217;s telecommunications business in Uzbekistan.</p>



<p class="wp-block-paragraph">The U.S. Department of Justice stated that Telia and Coscom structured and concealed the payments through various transactions, including payments to a shell company beneficially owned by the Uzbek official. The payments enabled Telia and Coscom to obtain telecommunications business and valuable telecom assets and to continue operating in the Uzbek market.</p>



<p class="wp-block-paragraph">The matter resulted in coordinated enforcement proceedings in the United States and the Netherlands. On 21 September 2017, Coscom pleaded guilty in the United States to conspiracy to violate the anti-bribery provisions of the Foreign Corrupt Practices Act (FCPA), while Telia entered into a deferred prosecution agreement and admitted participating in the charged conspiracy. Telia also reached related resolutions with the U.S. Securities and Exchange Commission and the Dutch Public Prosecution Service.</p>



<p class="wp-block-paragraph">The combined U.S. and Dutch criminal and regulatory resolution totalled $965,773,949 and included criminal penalties, forfeiture, disgorgement and prejudgment interest. Telia also agreed to strengthen its internal controls and cooperate with the authorities&#8217; continuing investigations. <a href="https://www.justice.gov/archives/opa/pr/telia-company-ab-and-its-uzbek-subsidiary-enter-global-foreign-bribery-resolution-more-965"><strong>Telia Company AB and Its Uzbek Subsidiary Enter Into a Global Foreign Bribery Resolution of More Than $965 Million for Corrupt Payments in Uzbekistan</strong></a></p>



<h4 class="wp-block-heading">Corporate Compliance and Regulatory Risk</h4>



<p class="wp-block-paragraph">The case illustrates a different form of telecommunications-sector corporate exposure from the sanctions, surveillance and human-rights matters discussed elsewhere in this article. Here, the principal risks involved corruption, regulatory influence, telecommunications licences, third-party payments, internal controls, corporate governance and exposure to foreign anti-bribery laws.</p>



<p class="wp-block-paragraph">The Telia case also demonstrates how telecommunications licences and access to regulated markets can create significant compliance risks where government officials or politically connected intermediaries have influence over market entry or regulatory decisions.</p>



<h3 class="wp-block-heading">African Union — Digital Infrastructure and Surveillance Risk</h3>



<p class="wp-block-paragraph"><strong>2020 | Security cameras, digital infrastructure and suspected cyber-espionage</strong></p>



<p class="wp-block-paragraph">A further example shows how corporate and infrastructure-related risk can extend beyond conventional telecommunications networks.</p>



<p class="wp-block-paragraph">In December 2020, Reuters reported suspicious activity at the African Union (AU) headquarters in Addis Ababa. Technology staff found suspected Chinese hackers siphoning footage from the organisation&#8217;s security-camera servers. An internal AU memorandum reviewed by Reuters said the cameras covered offices, parking areas, corridors and meeting rooms. Information from Japanese cyber researchers reportedly prompted the investigation.</p>



<p class="wp-block-paragraph">Reuters also reported that Chinese workers had built the AU&#8217;s conference centre and that Chinese technicians continued to assist with the organisation&#8217;s digital infrastructure. The Chinese mission to the AU denied that the organisation had reported being hacked and rejected the allegations.</p>



<p class="wp-block-paragraph">The incident illustrates a broader corporate and infrastructure-security issue. Organisations that rely on externally supplied or maintained digital infrastructure may also need to consider data access, cybersecurity, surveillance capabilities, supply-chain security and control over networked systems.</p>



<p class="wp-block-paragraph">The report does not establish that the infrastructure supplier was responsible for the alleged cyber intrusion. Rather, it illustrates why organisations may need to consider cybersecurity and control of digital infrastructure when assessing telecommunications and technology projects.</p>



<p class="wp-block-paragraph">Source: Reuters, “Exclusive-Suspected Chinese hackers stole camera footage from African Union – memo,” 16 December 2020. The Reuters report is reproduced on EMFSA with attribution to Reuters: <a href="https://www.emfsa.co.za/news/exclusive-suspected-chinese-hackers-stole-camera-footage-from-african-union-memo/"><strong>EMFSA — African Union camera-footage report</strong></a></p>



<h3 class="wp-block-heading"><strong>Corporate risk is not necessarily the same thing as corporate wrongdoing.</strong></h3>



<p class="wp-block-paragraph">Vodafone provides a different perspective. Its corporate reporting identifies network shutdowns and law-enforcement assistance as human-rights issues and describes procedures for responding to government demands for communications data and network restrictions. Its reporting also illustrates how telecommunications companies may disclose activities involving countries subject to sanctions, even where the company does not operate directly in those countries.</p>



<p class="wp-block-paragraph">&nbsp;<strong><a href="https://www.sec.gov/Archives/edgar/data/839923/000119312526235425/d143190d20f.htm">Vodafone, Annual Report/Form 20-F</a>&nbsp;</strong></p>



<h3 class="wp-block-heading">Company Disclosures&nbsp;</h3>



<p class="wp-block-paragraph">Telecommunications companies operate within increasingly complex financial, sustainability and regulatory reporting frameworks. Depending on the applicable rules and the materiality of an event, companies may need to disclose significant legal, regulatory, operational or financial risks in their corporate reporting. Issues such as surveillance, human-rights litigation, network shutdowns, sanctions and other regulatory matters can therefore have consequences beyond the immediate legal issue. They may also affect a company&#8217;s operations, finances, reputation and reporting obligations. </p>



<p class="wp-block-paragraph"><strong><a href="https://www.ifrs.org/sustainability/knowledge-hub/ifrs-resources/">IFRS Foundation resources</a> </strong></p>



<h4 class="wp-block-heading"><strong>AI Disclosure</strong></h4>



<p class="wp-block-paragraph">AI tools helped prepare this article through language editing, formatting, editorial assistance and research-support tasks. The author reviewed the sources and factual claims, reviewed and approved the final article, and remains responsible for its accuracy, interpretation and presentation.</p>
<p>The post <a href="https://www.emfsa.co.za/news/telecommunications-infrastructure-and-corporate-risk/">Telecommunications Infrastructure and Corporate Risk</a> appeared first on <a href="https://www.emfsa.co.za">EMFSA</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
